Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G1B,Phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,49244,-0.0813897361157104,0.0258190037075321,-0.131994983382473,-0.0307844888489476,0.00162167655095425
PLA2G1B,Phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,45452,-0.04294543239557,0.0294312277724787,-0.100630638829628,0.0147397740384883,0.144530367880015
PLA2G1B,Phospholipase A2,Physical activities,X1070.Time spent watching television (TV),50428,-0.0519200995664226,0.0256882293475269,-0.102269029087575,-0.00157117004526985,0.0432728996799563
PLA2G1B,Phospholipase A2,Physical activities,X1080.Time spent using computer,45382,-0.030810262518895,0.0275095138963701,-0.0847289097557803,0.0231083847179904,0.262732349391626
PLA2G1B,Phospholipase A2,Physical activities,X1090.Time spent driving,44257,-0.037828354144902,0.0284803295631507,-0.0936498000886775,0.0179930917988734,0.184117856678076
PLA2G1B,Phospholipase A2,Lifestyle factors,X1160.Sleep duration,52242,-0.0477775277599124,0.0241204113240427,-0.095053533955036,-0.000501521564788728,0.0476241960141522
PLA2G1B,Phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34622,-0.0123942301266611,0.0138962115919893,-0.0396308048469601,0.0148423445936378,0.372458798943895
PLA2G1B,Phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34622,0.0194688476037873,0.0136364270411636,-0.00725854939689334,0.0461962446044679,0.153404692765215
PLA2G1B,Phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34622,0.0159031028908683,0.0160000475059766,-0.0154569902208459,0.0472631960025825,0.320273948760703
PLA2G1B,Phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34622,0.00994717121075548,0.0165727340417955,-0.0225353875111638,0.0424297299326747,0.548376896972069
PLA2G1B,Phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34622,0.0415663960422578,0.017075241967805,0.00809892178535992,0.0750338702991557,0.0149364468381423
PLA2G1B,Phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34622,0.0571594386316539,0.0328775843707612,-0.00728062673503812,0.121599503998346,0.0821419338700004
PLA2G1B,Phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34622,0.0222816718680164,0.0337627094178934,-0.0438932385910547,0.0884565823270875,0.509300575555704
PLA2G1B,Phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34622,-0.00442617269832636,0.0239994176544322,-0.0514650313010135,0.0426126859043607,0.853680915964351
PLA2G1B,Phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34622,0.0220677499879475,0.0176823581088753,-0.0125896719054481,0.0567251718813432,0.212054749128293
PLA2G1B,Phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34622,-0.000351609268248148,0.0123955938392566,-0.0246469731931911,0.0239437546566948,0.977371034111197
PLA2G1B,Phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34622,0.0280103027480868,0.017628059660069,-0.00654069418564838,0.0625612996818221,0.112098528675729
PLA2G1B,Phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34622,0.00546364970083403,0.0100640652512675,-0.0142619181916503,0.0251892175933184,0.587218883461152
PLA2G1B,Phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34622,0.0150063460193138,0.0129182447689576,-0.0103134137278431,0.0403261057664708,0.245407609963107
PLA2G1B,Phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34622,0.0133174374889059,0.0196474747066828,-0.0251916129361924,0.0518264879140043,0.497900846257899
PLA2G1B,Phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34622,0.00924558694153633,0.0185615071078075,-0.0271349669897663,0.045626140872839,0.618419932313096
PLA2G1B,Phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34622,0.0180411475036682,0.0228444219944435,-0.026733919605441,0.0628162146127774,0.429697186899561
PLA2G1B,Phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34622,0.0162332419819532,0.021422964430908,-0.0257557683026265,0.058222252266533,0.448617511696036
PLA2G1B,Phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34622,-0.00386539820114641,0.0143892459886936,-0.0320683203389859,0.024337523936693,0.788218767977979
PLA2G1B,Phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34622,0.0201238389762183,0.0136748308916558,-0.00667882957142703,0.0469265075238636,0.141158998163566
PLA2G1B,Phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34622,-0.017412210206975,0.0168778190098651,-0.0504927354663105,0.0156683150523605,0.302253510161655
PLA2G1B,Phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,34629,-0.0174365355423048,0.0421156340886662,-0.0999831783560906,0.065110107271481,0.678870824116136
PLA2G1B,Phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34631,-0.00828259259871603,0.0415504810041254,-0.0897215353668017,0.0731563501693697,0.842002066302634
PLA2G1B,Phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34629,-0.0324082572027084,0.0455495297045959,-0.121685335423716,0.0568688210182996,0.476793035979149
PLA2G1B,Phospholipase A2,Health and medical history,X120098.Mobility problems today,34634,-0.0692953015495933,0.0511081797468884,-0.169467333853495,0.030876730754308,0.175173605092735
PLA2G1B,Phospholipase A2,Health and medical history,X120099.Self-care problems today,34634,-0.120074277670217,0.0795337616977091,-0.275960450597727,0.0358118952572927,0.131142398858208
PLA2G1B,Phospholipase A2,Health and medical history,X120100.Problems doing usual activities,34634,0.00890783457652868,0.0482273841790471,-0.0856178384144037,0.103433507567461,0.853463973516255
PLA2G1B,Phospholipase A2,Health and medical history,X120101.Pain or discomfort today,34634,0.0631219698587292,0.042082533798551,-0.0193597963864308,0.145603736103889,0.133654981917175
PLA2G1B,Phospholipase A2,Health and medical history,X120102.Anxiety or depression today,34634,0.0476949957017407,0.0498585575125067,-0.0500277770227724,0.145417768426254,0.33878762463211
PLA2G1B,Phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,34600,-0.0034233100131107,0.00435230773626602,-0.0119538331761921,0.00510721314997071,0.431562375035881
PLA2G1B,Phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34618,-0.0414699776125444,0.0500476218343887,-0.139563316407946,0.0566233611828573,0.407343313662316
PLA2G1B,Phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34603,0.0449324129383696,0.0511344945756503,-0.0552911964299049,0.145156022306644,0.379577966552832
PLA2G1B,Phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34623,-0.00933549346303331,0.0411957806090018,-0.0900792234566767,0.0714082365306101,0.820729099697062
PLA2G1B,Phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34623,0.00359951111785915,0.042226146011323,-0.0791637350643338,0.0863627573000521,0.932069269204971
PLA2G1B,Phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34620,-0.0365071022533848,0.0518431030192844,-0.138119584171182,0.0651053796644127,0.481333212529318
PLA2G1B,Phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34593,-0.056217321062434,0.0533692728250529,-0.160821095799538,0.0483864536746696,0.292197481737923
PLA2G1B,Phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34625,-0.00705960382199671,0.0534600302880274,-0.11184126318653,0.097722055542537,0.894944152088144
PLA2G1B,Phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34609,-0.0312490224726207,0.0797866356581088,-0.187630828362514,0.125132783417273,0.695319170776293
PLA2G1B,Phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34557,-0.169928536234629,0.104536120589424,-0.374819332589899,0.0349622601206423,0.104075197913642
PLA2G1B,Phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31562,0.00375594131139789,0.0549201050152823,-0.103887464518555,0.111399347141351,0.945477605245025
PLA2G1B,Phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49138,-0.168658469478766,0.0568255845495537,-0.280036615195891,-0.0572803237616407,0.00300022884169508
PLA2G1B,Phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47838,-0.094734799076061,0.0349897713196488,-0.163314750862573,-0.0261548472895494,0.00678401485493668
PLA2G1B,Phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51208,-0.0408900460928242,0.0247457149382529,-0.0893916473717999,0.00761155518615157,0.0984626488801901
PLA2G1B,Phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50671,-0.034012664231749,0.0263957313211317,-0.0857482976211671,0.0177229691576692,0.197559835417096
PLA2G1B,Phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51195,0.142807359212631,0.0264295681432415,0.0910054056518774,0.194609312773384,6.59657330942867e-08
PLA2G1B,Phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49620,0.165907683833515,0.0279163811180905,0.111191576842058,0.220623790824973,2.83410902497318e-09
PLA2G1B,Phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52472,0.00863564286812884,0.0549734607175778,-0.0991123401383237,0.116383625874581,0.875177006562976
PLA2G1B,Phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52472,-0.0370161543754102,0.0241744719644502,-0.0843981194257326,0.0103658106749122,0.125728953117971
PLA2G1B,Phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52472,-0.0265498556388575,0.0240509818298376,-0.0736897800253391,0.0205900687476242,0.269646221442285
PLA2G1B,Phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52472,-0.0345686181685358,0.0241279372661011,-0.081859375210094,0.0127221388730224,0.151948324674267
PLA2G1B,Phospholipase A2,Diet and food preferences,X1438.Bread intake,51589,0.000822476625424721,0.00288766354996045,-0.00483734393249775,0.00648229718334719,0.775780914194864
PLA2G1B,Phospholipase A2,Diet and food preferences,X1458.Cereal intake,50818,0.3222081385715,0.0251411360051247,0.272931512001456,0.371484765141545,1.7173539718815e-37
PLA2G1B,Phospholipase A2,Diet and food preferences,X1488.Tea intake,51368,0.0215775263829428,0.00272328434753419,0.0162398890617758,0.0269151637041098,2.3989138973973e-15
PLA2G1B,Phospholipase A2,Diet and food preferences,X1498.Coffee intake,50103,-0.0957348224950699,0.0250218510200801,-0.144777650494427,-0.046691994495713,0.000130518102177642
PLA2G1B,Phospholipase A2,Diet and food preferences,X1528.Water intake,50431,0.001110658771934,0.0256811107584631,-0.0492243183146537,0.0514456358585217,0.965504102379936
PLA2G1B,Phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,43276,-0.129866197396884,0.0297906880970974,-0.188255946067195,-0.0714764487265734,1.31156883877171e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43268,-0.107624483378654,0.0305698689826187,-0.167541426584586,-0.0477075401727209,0.00043154784936554
PLA2G1B,Phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,43320,-0.136545555021765,0.0335849630287164,-0.202372082558049,-0.070719027485481,4.80818965447884e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,43241,-0.0589835923011808,0.0334080361198646,-0.124463343096115,0.00649615849375391,0.0774869474631627
PLA2G1B,Phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,43312,0.0698327464271441,0.060334578967791,-0.0484230283497263,0.188088521204015,0.24711300217836
PLA2G1B,Phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45871,-0.0227184976151812,0.0290789725030207,-0.0797132837211018,0.0342762884907395,0.434652745457841
PLA2G1B,Phospholipase A2,Health and medical history,X1807.Father's age at death,40928,0.00457208390519947,0.00385494408032775,-0.00298360649224292,0.0121277743026419,0.235626493474543
PLA2G1B,Phospholipase A2,Health and medical history,X1845.Mother's age,40181,0.00891091176011328,0.00580915142974384,-0.00247502504218465,0.0202968485624112,0.125062865021946
PLA2G1B,Phospholipase A2,Health and medical history,X1873.Number of full brothers,51960,-0.0273039030935808,0.0242562553211779,-0.0748461635230895,0.0202383573359279,0.260325940413506
PLA2G1B,Phospholipase A2,Health and medical history,X1883.Number of full sisters,51962,0.0276481764410341,0.0242981597695042,-0.0199762167071941,0.0752725695892622,0.255183966179925
PLA2G1B,Phospholipase A2,Physical measures,X20015.Sitting height,52236,-0.0131426912686313,0.00364666860336931,-0.0202901617312352,-0.0059952208060275,0.0003138608305436
PLA2G1B,Phospholipase A2,Cognitive function,X20016.Fluid intelligence score,32868,0.0410791093079258,0.0413582966559893,-0.0399831521378132,0.122141370753665,0.320615074029339
PLA2G1B,Phospholipase A2,Cognitive function,X20018.Prospective memory result,33197,-0.0314567722060069,0.0571967325073312,-0.143562367920376,0.0806488235083623,0.582349686490531
PLA2G1B,Phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32776,-0.00504975187632293,0.00506937864400899,-0.0149857340185805,0.00488623026593469,0.319214810899454
PLA2G1B,Phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32768,0.000851169209277905,0.00504278875893824,-0.00903269675824104,0.0107350351767968,0.865966140934122
PLA2G1B,Phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52155,0.00166982668320632,0.0028986045271607,-0.00401143819002865,0.0073510915564413,0.564566020524013
PLA2G1B,Phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49174,0.00360195474637391,0.00625192097995162,-0.00865181037433127,0.0158557198670791,0.564528598168586
PLA2G1B,Phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48739,-0.0219440877851731,0.0142184923414452,-0.0498123327744057,0.00592415720405944,0.122758978450042
PLA2G1B,Phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48706,-0.0280850124622821,0.0191260598661888,-0.0655720898000122,0.00940206487544802,0.142003915630492
PLA2G1B,Phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48738,0.00297459788442293,0.0146464309867128,-0.0257324068495342,0.0316816026183801,0.839063455484341
PLA2G1B,Phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48740,0.0102466067693453,0.0106653448459799,-0.0106574691287753,0.0311506826674658,0.336693034654863
PLA2G1B,Phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48902,-0.0104746906137133,0.00822544835094075,-0.0265965693815572,0.00564718815413055,0.202870508692252
PLA2G1B,Phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48842,-0.0138248199873535,0.0106753052201632,-0.0347484182188735,0.0070987782441664,0.195322511907407
PLA2G1B,Phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48741,-0.0140891849626316,0.0128777422048266,-0.0393295596840918,0.0111511897588285,0.273933727716317
PLA2G1B,Phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48868,-0.0341078650773599,0.01018839716101,-0.0540771235129396,-0.0141386066417802,0.000816004791739056
PLA2G1B,Phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,49026,0.00243401063314887,0.00646144914739826,-0.0102304296957517,0.0150984509620495,0.706401724216003
PLA2G1B,Phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48873,-0.0157097588455226,0.0088346400357831,-0.0330256533156574,0.00160613562461233,0.0753831214944006
PLA2G1B,Phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50249,0.0115326968709103,0.00750171679382549,-0.00317066804498768,0.0262360617868082,0.124221813199524
PLA2G1B,Phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50117,0.0241411814396035,0.0121332840490428,0.000359944703479654,0.0479224181757273,0.0466381075053268
PLA2G1B,Phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50062,-0.00598751106106048,0.0256178098401293,-0.0561984183477138,0.0442233962255929,0.815200653823723
PLA2G1B,Phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50109,0.0199574418774412,0.0109493052172262,-0.00150319634832205,0.0414180801032045,0.068358228046136
PLA2G1B,Phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50193,-0.0104692722746207,0.00889613970245618,-0.0279057060914348,0.00696716154219342,0.239272738322396
PLA2G1B,Phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50116,-0.0470859446557062,0.0144890006757627,-0.0754843859802011,-0.0186875033312112,0.00115643014285984
PLA2G1B,Phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50093,-0.0100992461739026,0.0137257916485443,-0.0370017978050495,0.0168033054572442,0.461867483857241
PLA2G1B,Phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50128,-0.00226062290018281,0.0104225353644207,-0.0226887922144474,0.0181675464140818,0.828289832916834
PLA2G1B,Phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50132,-0.00967904654133028,0.0122252321453306,-0.0336405015461782,0.0142824084635177,0.428527015377907
PLA2G1B,Phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50349,0.0120212821047707,0.00589197029691346,0.000473020322820331,0.0235695438867211,0.0413321230347985
PLA2G1B,Phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50185,-0.0229702832223044,0.0091453373138452,-0.040895144357441,-0.00504542208716782,0.0120212788961073
PLA2G1B,Phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,47344,-0.0129611018144371,0.0119923810629997,-0.0364661686979166,0.0105439650690423,0.279806968318427
PLA2G1B,Phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,47227,0.0220462290543759,0.0666354110145163,-0.108559176534076,0.152651634642828,0.740761853607303
PLA2G1B,Phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,47226,0.0736052711521975,0.0576080172394655,-0.0393064426371548,0.18651698494155,0.201370934478602
PLA2G1B,Phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,47312,0.0138915264667339,0.0109811777701927,-0.00763158196284384,0.0354146348963116,0.205872909963529
PLA2G1B,Phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,47232,-0.048813019936907,0.0368259162591636,-0.120991815804868,0.0233657759310535,0.185015913915315
PLA2G1B,Phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,47246,-0.0174958420565241,0.0207081945306495,-0.058083903336597,0.0230922192235489,0.398189109999955
PLA2G1B,Phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,47234,0.00718775424047488,0.0278827167495405,-0.0474623705886246,0.0618378790695743,0.796574886720164
PLA2G1B,Phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,47241,0.00753847130508003,0.0247769472837163,-0.041024345371004,0.0561012879811641,0.760937526075998
PLA2G1B,Phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,47246,-0.00068068872870439,0.0166411636948116,-0.0332973695705352,0.0319359921131264,0.967372846316452
PLA2G1B,Phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,47251,-0.0339796925442246,0.0217511864750179,-0.0766120180352597,0.00865263294681055,0.118254527612905
PLA2G1B,Phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47437,0.00201275201668006,0.00771623504633128,-0.0131110686741292,0.0171365727074894,0.794213250538545
PLA2G1B,Phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,47328,-0.0252878182986063,0.0112971465279415,-0.0474302254933717,-0.00314541110384095,0.0252026735269453
PLA2G1B,Phospholipase A2,Mental health,X20127.Neuroticism score,46840,0.0547478638498247,0.0248528775037406,0.00603622394249315,0.103459503757156,0.0276132231375145
PLA2G1B,Phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32868,-0.0531937678787166,0.0421213884269985,-0.135751689195634,0.0293641534382004,0.20666922788243
PLA2G1B,Phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,31765,-0.0244307235188726,0.00604592222094852,-0.0362807310719317,-0.0125807159658135,5.3760251284609e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31765,-0.0232699033743822,0.0056529760699642,-0.0343497364715121,-0.0121900702772524,3.88751468952238e-05
PLA2G1B,Phospholipase A2,Cognitive function,X20191.Fluid intelligence score,31474,0.140505056010531,0.0454851392051501,0.0513541831684365,0.229655928852625,0.00201534314223888
PLA2G1B,Phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31474,0.0825130931807315,0.0465096307976645,-0.00864578318269095,0.173671969544154,0.0760853587358642
PLA2G1B,Phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,30821,0.0616083089179061,0.0483384897972283,-0.0331351310846613,0.156351748920474,0.202522244119687
PLA2G1B,Phospholipase A2,Physical measures,X20255.Spirometry QC measure,45270,-0.0164837662684382,0.0329054332273858,-0.0809784153941143,0.0480108828572379,0.61641596407291
PLA2G1B,Phospholipase A2,Eye measures,X20261.avMSE,30012,-0.0119021361528278,0.00635691426897124,-0.0243616881200114,0.00055741581435588,0.0612106501793863
PLA2G1B,Phospholipase A2,Eye measures,X20262.Myopia diagnosis,30012,0.111359373404188,0.0597149046732345,-0.00568183975535204,0.228400586563727,0.0622499399627188
PLA2G1B,Phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,39991,-0.0432174513912787,0.00374525590654442,-0.0505581529681058,-0.0358767498144517,1.10389091487467e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40027,-0.0118983819859725,0.00371338389674111,-0.0191766144235851,-0.00462014954835996,0.00135706551727202
PLA2G1B,Phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32783,0.00523774136621427,0.0178754418450916,-0.0297981246501654,0.0402736073825939,0.769518835177823
PLA2G1B,Phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32780,-0.0405101599774821,0.0358613803620348,-0.11079846548707,0.029778145532106,0.258661730659097
PLA2G1B,Phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32778,0.0527570035606593,0.0397363605912837,-0.0251262631982567,0.130640270319575,0.184319220743559
PLA2G1B,Phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32778,-0.00452413637791852,0.01728677761269,-0.038406220498791,0.0293579477429539,0.79355045841867
PLA2G1B,Phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32778,-0.0306332157456148,0.0278244750317772,-0.0851691868078981,0.0239027553166684,0.270950323990839
PLA2G1B,Phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32785,0.0197831150774526,0.0358929281541894,-0.0505670241047586,0.0901332542596638,0.58153075203161
PLA2G1B,Phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32785,0.0121340915757827,0.0236694266882655,-0.0342579847332177,0.058526167884783,0.608210040651052
PLA2G1B,Phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32785,0.0162453609593324,0.025787438361149,-0.0342980182285196,0.0667887401471844,0.528729111277068
PLA2G1B,Phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32785,0.0182958406731583,0.0401261948465189,-0.0603515012260189,0.0969431825723354,0.648431612517196
PLA2G1B,Phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32785,0.0563959939371875,0.0464467422456063,-0.0346396208642009,0.147431608738576,0.22470053211755
PLA2G1B,Phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32785,0.0226566151668406,0.0265695681692819,-0.0294197384449519,0.074732968778633,0.393833032933401
PLA2G1B,Phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32785,0.0513804727501773,0.0453649147593825,-0.0375347601782124,0.140295705678567,0.257411117786343
PLA2G1B,Phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32785,0.0465136951401264,0.0347168848164922,-0.0215313991001984,0.114558789380451,0.180344366451903
PLA2G1B,Phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32788,0.0388170170288474,0.0466383327176557,-0.0525941150977578,0.130228149155453,0.405262706485841
PLA2G1B,Phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32788,-0.0234692413020935,0.0231392746254601,-0.0688222195679952,0.0218837369638082,0.310486177863887
PLA2G1B,Phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32788,-0.0251097496437673,0.031818884209551,-0.0874747626944872,0.0372552634069526,0.430047552779695
PLA2G1B,Phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32788,-0.0788143428685987,0.0527838188441346,-0.182270627803103,0.0246419420659051,0.135432352408333
PLA2G1B,Phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,35526,-0.0529262244671754,0.0365987880867989,-0.124659849117301,0.0188074001829504,0.148170546847649
PLA2G1B,Phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,35526,-0.076716526855839,0.036281504192908,-0.147828275073939,-0.00560477863773935,0.0344954334288977
PLA2G1B,Phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,35526,0.115790702036771,0.0369803158773563,0.0433092829171529,0.18827212115639,0.00174557118031202
PLA2G1B,Phospholipase A2,Diet and food preferences,X20603.Liking for apples,35526,0.0296735691886263,0.0372895408487621,-0.0434139308749473,0.1027610692522,0.426187060342995
PLA2G1B,Phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,35526,-0.10305815226793,0.0374434596642127,-0.176447333209786,-0.0296689713260726,0.00592576260021694
PLA2G1B,Phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,35526,-0.00023986655625647,0.0363754574879542,-0.0715357632326467,0.0710560301201338,0.99473875124795
PLA2G1B,Phospholipase A2,Diet and food preferences,X20606.Liking for avocados,35526,-0.0471252713186227,0.0371555555401368,-0.119950160177291,0.0256996175400454,0.204707709160018
PLA2G1B,Phospholipase A2,Diet and food preferences,X20607.Liking for bacon,35526,-0.0971544602611201,0.0369365692760699,-0.169550136042217,-0.024758784480023,0.00854203081698766
PLA2G1B,Phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,35526,-0.0268695293422807,0.0368801804869883,-0.0991546830967778,0.0454156244122165,0.466283746739262
PLA2G1B,Phospholipase A2,Diet and food preferences,X20609.Liking for bananas,35526,0.0338394767944479,0.0379202147161363,-0.0404841440491793,0.108163097638075,0.372204379105007
PLA2G1B,Phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35526,-0.112271499196969,0.0366411472565222,-0.184088147819753,-0.0404548505741855,0.00218837223151227
PLA2G1B,Phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,35526,-0.145299767575529,0.0369942559780821,-0.21780850929257,-0.0727910258584876,8.62812633125547e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,35526,-0.0876075537897613,0.0371570800464808,-0.160435430680864,-0.0147796768986588,0.018401900274553
PLA2G1B,Phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,35526,-0.035530404120293,0.0366407992092179,-0.10734637057036,0.036285562329774,0.332218603470924
PLA2G1B,Phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,35526,0.00393134548103703,0.0367800183524641,-0.0681574904897925,0.0760201814518666,0.914879610530026
PLA2G1B,Phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,35526,0.0854025949593823,0.0367453603882317,0.0133816885984482,0.157423501320316,0.0201332916653168
PLA2G1B,Phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,35526,-0.081764040085197,0.0366544270914021,-0.153606717184345,-0.00992136298604893,0.0257217515278623
PLA2G1B,Phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,35526,-0.057618214432066,0.0374079947833208,-0.130937884207375,0.0157014553432427,0.123522984011993
PLA2G1B,Phospholipase A2,Diet and food preferences,X20618.Liking for black olives,35526,-0.0696015938266829,0.03687520076394,-0.141876987324005,0.00267379967063962,0.0591191922983532
PLA2G1B,Phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,35526,-0.135216973705725,0.0374662971730087,-0.208650916164823,-0.0617830312466283,0.000308632318077771
PLA2G1B,Phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,35526,-0.107325517181664,0.0367422135902294,-0.179340255818514,-0.0353107785448144,0.00349532794799712
PLA2G1B,Phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,35526,-0.0996050251393321,0.036727645198891,-0.171591209729158,-0.0276188405495058,0.00669785860843831
PLA2G1B,Phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,35526,-0.015346377247304,0.0365940301849982,-0.0870706764099005,0.0563779219152925,0.674954695163098
PLA2G1B,Phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,35526,-0.054889114992916,0.0379985846649374,-0.129366340936193,0.0195881109503613,0.148624077541751
PLA2G1B,Phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,35526,0.0759073271175395,0.036772777870782,0.00383268249080686,0.147981971744272,0.0390183595156758
PLA2G1B,Phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,35526,-0.0306096075685132,0.0367639079708198,-0.10266686719132,0.0414476520542936,0.405087756852106
PLA2G1B,Phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),35526,-0.0841211309576785,0.0365826009306227,-0.155823028781699,-0.0124192331336579,0.0214950216410508
PLA2G1B,Phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,35526,-0.0727067709288493,0.036399625632083,-0.144050037167732,-0.00136350468996663,0.0457985111611031
PLA2G1B,Phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,35526,-0.0417174063765131,0.0372063531462966,-0.114641858543254,0.0312070457902282,0.262207042024152
PLA2G1B,Phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,35526,0.099923008387409,0.036717298763416,0.0279571028111137,0.171888913963704,0.00650996150422982
PLA2G1B,Phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,35526,-0.124087290983377,0.0370186668068064,-0.196643877924718,-0.0515307040420367,0.000804795285253833
PLA2G1B,Phospholipase A2,Diet and food preferences,X20631.Liking for cake,35526,0.152224240455548,0.0367342431465086,0.0802251238883913,0.224223357022705,3.43811370517639e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,35526,0.170116770874764,0.0365369361322667,0.098504376055521,0.241729165694006,3.25936984876793e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20633.Liking for capers,35526,-0.102087913367747,0.0362709104887234,-0.173178897925645,-0.030996928809849,0.00489206501075821
PLA2G1B,Phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,35526,-0.0984872033838753,0.037280044482872,-0.171556090570304,-0.0254183161974462,0.00825717249773176
PLA2G1B,Phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,35526,0.0666953640031538,0.0367138971056335,-0.0052638743238879,0.138654602330196,0.0693003037225098
PLA2G1B,Phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,35526,0.00441834659319674,0.0366990349645166,-0.0675117619372559,0.0763484551236494,0.904173054761565
PLA2G1B,Phospholipase A2,Diet and food preferences,X20637.Liking for cherries,35526,0.0452334724653814,0.0382183394550224,-0.0296744728664625,0.120141417797225,0.236613752919703
PLA2G1B,Phospholipase A2,Diet and food preferences,X20638.Liking for chicken,35526,-0.0158264323616617,0.0382499902556137,-0.0907964132626646,0.0591435485393411,0.679055264042058
PLA2G1B,Phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,35526,-0.12644614196054,0.0367735161479708,-0.198522233610563,-0.054370050310517,0.000586967817681859
PLA2G1B,Phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,35526,-0.0397715424057742,0.0371168576609915,-0.112520583421317,0.0329774986097692,0.283956812059798
PLA2G1B,Phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,35526,-0.0184454479170477,0.0569225871780584,-0.130013718786042,0.0931228229519467,0.745910202920402
PLA2G1B,Phospholipase A2,Diet and food preferences,X20642.Liking for cod,35526,-0.048406036416269,0.0372084816966202,-0.121334660541645,0.0245225877091067,0.193304392540401
PLA2G1B,Phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,35526,0.0446094519756334,0.0399533905756064,-0.0336991935525552,0.122918097503822,0.264215214703553
PLA2G1B,Phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,35526,-0.0506537434985378,0.0368853894529136,-0.122949106826248,0.0216416198291727,0.169693618249409
PLA2G1B,Phospholipase A2,Diet and food preferences,X20645.Liking for coriander,35526,-0.0971452174326726,0.0367463408490561,-0.169168045496823,-0.0251223893685226,0.00821222166914465
PLA2G1B,Phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,35526,0.0615703300797166,0.0364663779484463,-0.00990377069923812,0.133044430858671,0.0913586006964203
PLA2G1B,Phospholipase A2,Diet and food preferences,X20647.Liking for cream,35526,-0.000172038990737095,0.0362729571948304,-0.0712670350926047,0.0709229571111305,0.996215809058308
PLA2G1B,Phospholipase A2,Diet and food preferences,X20648.Liking for croissant,35526,0.0746322969361898,0.0366195153792896,0.00285804679278227,0.146406547079597,0.0415677496709022
PLA2G1B,Phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,35526,-0.0668224230521644,0.0370750416334966,-0.139489504653818,0.00584465854948898,0.0715152369548276
PLA2G1B,Phospholipase A2,Diet and food preferences,X20650.Liking for curry,35526,-0.0870729449425715,0.0374830934917907,-0.160539808186481,-0.0136060816986619,0.02019667681494
PLA2G1B,Phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,35526,0.0607032532120011,0.0371484765148425,-0.0121077607570902,0.133514267181092,0.102270918548849
PLA2G1B,Phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,35526,0.115419403383862,0.0367542431115925,0.0433810868851406,0.187457719882583,0.00169195820718159
PLA2G1B,Phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35526,-0.113006251038588,0.0373610576083795,-0.186233923951012,-0.0397785781261641,0.00249416131857814
PLA2G1B,Phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,35526,0.0600754601195113,0.0369536140100707,-0.0123536233402272,0.13250454357925,0.104040695878314
PLA2G1B,Phospholipase A2,Diet and food preferences,X20655.Liking for eggs,35526,-0.0776215317448973,0.0376179238647547,-0.151352662519816,-0.00389040096997806,0.0390949420259115
PLA2G1B,Phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,35526,0.0812693933820098,0.0365170258311584,0.00969602275293946,0.15284276401108,0.0260653633391538
PLA2G1B,Phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,35526,0.0956765521756106,0.0366847550860839,0.0237744322068862,0.167578672144335,0.00911694110867015
PLA2G1B,Phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35526,-0.0767696222767153,0.0372747484173776,-0.149828129174775,-0.00371111537865521,0.0394626724701141
PLA2G1B,Phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,35526,-0.0340898473376892,0.0365716638678703,-0.105770308518715,0.0375906138433365,0.351284379589719
PLA2G1B,Phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,35526,-0.139184166573729,0.0391803317563381,-0.215977616816151,-0.062390716331306,0.000383243123693763
PLA2G1B,Phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,35526,-0.0283119096734532,0.0365199338937613,-0.0998909801052253,0.0432671607583189,0.438210409148303
PLA2G1B,Phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,35526,-0.122033382061924,0.0365624930324314,-0.19369586840549,-0.0503708957183588,0.000847497539486573
PLA2G1B,Phospholipase A2,Diet and food preferences,X20663.Liking for fruit,35526,0.0200940675497069,0.040106637717498,-0.0585149423765891,0.0987030774760029,0.616369316498472
PLA2G1B,Phospholipase A2,Diet and food preferences,X20664.Liking for garlic,35526,-0.157807975515001,0.0374740859336712,-0.231257183944997,-0.0843587670850055,2.56013227383421e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,35526,-0.0803363781493615,0.0365052358873455,-0.151886640488559,-0.00878611581016439,0.0277781545949648
PLA2G1B,Phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,35526,-0.0103135453202607,0.0362619284031636,-0.0813869249904614,0.06075983434994,0.776095114791624
PLA2G1B,Phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,35526,-0.028571844423162,0.0363295011866284,-0.0997776667489536,0.0426339779026296,0.431611695361615
PLA2G1B,Phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,35526,0.0779749112358009,0.0368357647178677,0.00577681238878024,0.150173010082822,0.0342957292932515
PLA2G1B,Phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,35526,0.0315770360435273,0.0364066609807324,-0.0397800194787083,0.102934091565763,0.385772355313667
PLA2G1B,Phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,35526,-0.180544117087811,0.0364459762072366,-0.251978230453995,-0.109110003721627,7.3819464244221e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,35526,0.0242432166165332,0.03651411803346,-0.0473244547290484,0.0958108879621148,0.506741264805111
PLA2G1B,Phospholipase A2,Diet and food preferences,X20672.Liking for green olives,35526,-0.093399841342066,0.0368604914023773,-0.165646404490726,-0.0211532781934066,0.011293912324606
PLA2G1B,Phospholipase A2,Diet and food preferences,X20673.Liking for haddock,35526,-0.0353782669952937,0.0369563647487741,-0.107812741902891,0.0370562079123035,0.338436540850446
PLA2G1B,Phospholipase A2,Diet and food preferences,X20674.Liking for ham,35526,-0.133182178528076,0.036625870250665,-0.204968884219379,-0.0613954728367724,0.000277788134022601
PLA2G1B,Phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,35526,-0.0916496791477876,0.0372375416247259,-0.16463526073225,-0.0186640975633248,0.0138610310316125
PLA2G1B,Phospholipase A2,Diet and food preferences,X20676.Liking for herring,35526,-0.0437247406656805,0.0362686314992307,-0.114811258404173,0.0273617770728116,0.228003903703402
PLA2G1B,Phospholipase A2,Diet and food preferences,X20677.Liking for honey,35526,0.0582725519968596,0.0365194439335786,-0.0133055581129544,0.129850662106674,0.110592222743239
PLA2G1B,Phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35526,-0.170642551759732,0.0363965596407585,-0.241979808655619,-0.0993052948638458,2.78437299502828e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,35526,0.105720775878798,0.0368226705875176,0.0335483415272634,0.177893210230332,0.00409810855170927
PLA2G1B,Phospholipase A2,Diet and food preferences,X20680.Liking for jam,35526,0.126136114149215,0.0367630240930818,0.0540805869267749,0.198191641371656,0.000603314516529147
PLA2G1B,Phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,35526,-0.00153010947066158,0.0367224214173674,-0.0735060554487018,0.0704458365073786,0.966764954399183
PLA2G1B,Phospholipase A2,Diet and food preferences,X20682.Liking for lager,35526,-0.126400790119173,0.0366475371043844,-0.198229962843767,-0.0545716173945798,0.000564460766658235
PLA2G1B,Phospholipase A2,Diet and food preferences,X20683.Liking for lamb,35526,-0.083394256159609,0.0367896996326412,-0.155502067439586,-0.0112864448796322,0.0234217412798517
PLA2G1B,Phospholipase A2,Diet and food preferences,X20684.Liking for lemons,35526,-0.0797262162221183,0.0368624252220958,-0.151976569657426,-0.00747586278681051,0.0305764913246398
PLA2G1B,Phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,35526,0.0270457107955378,0.036909323444711,-0.0452965631560958,0.0993879847471714,0.463718977874836
PLA2G1B,Phospholipase A2,Diet and food preferences,X20686.Liking for liver,35526,-0.0427787369161388,0.0367253503395371,-0.114760423581632,0.029202949749354,0.244112232639351
PLA2G1B,Phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,35526,-0.0435124314331473,0.0366771239355029,-0.115399594346733,0.0283747314804384,0.235502632077847
PLA2G1B,Phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,35526,0.0995662914890135,0.0365314278547729,0.0279646928936586,0.171167890084368,0.00643006381492416
PLA2G1B,Phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,35526,-0.0683425350711878,0.0363031323207075,-0.139496674419775,0.00281160427739893,0.0597859876939889
PLA2G1B,Phospholipase A2,Diet and food preferences,X20690.Liking for melon,35526,0.0246414526437278,0.0376969099231113,-0.0492444908055703,0.0985273960930259,0.513335387930576
PLA2G1B,Phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,35526,0.0531089823219062,0.0369032606163082,-0.019221408486058,0.12543937312987,0.150137528045049
PLA2G1B,Phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,35526,-0.00441920432095667,0.037992607912462,-0.0788847158293823,0.0700463071874689,0.907402938184136
PLA2G1B,Phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,35526,-0.0145436489276426,0.0367377843323889,-0.0865497062191248,0.0574624083638395,0.692202912336417
PLA2G1B,Phospholipase A2,Diet and food preferences,X20695.Liking for oranges,35526,0.00804919446171173,0.0373564827496151,-0.0651695117275338,0.0812679006509573,0.829404812430197
PLA2G1B,Phospholipase A2,Diet and food preferences,X20696.Liking for pasta,35526,0.00594876631512462,0.0373350191130156,-0.067227871146386,0.0791254037766353,0.873407896351333
PLA2G1B,Phospholipase A2,Diet and food preferences,X20697.Liking for pears,35526,0.0266878698946062,0.0371406916016625,-0.0461078856446523,0.0994836254338648,0.472425563671471
PLA2G1B,Phospholipase A2,Diet and food preferences,X20698.Liking for pizza,35526,0.0330424981038423,0.0366542519665975,-0.0387998357506888,0.104884831958373,0.36736015292095
PLA2G1B,Phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,35526,0.0789959210322781,0.0367663914632595,0.00693379376428956,0.151058048300267,0.0316874068880388
PLA2G1B,Phospholipase A2,Diet and food preferences,X20700.Liking for plums,35526,0.0518776135657438,0.0374179679461794,-0.0214616036087678,0.125216830740255,0.165640359831106
PLA2G1B,Phospholipase A2,Diet and food preferences,X20701.Liking for pollock,35526,-0.0397920963827821,0.0364939813127,-0.111320299755674,0.0317361069901099,0.275570871663628
PLA2G1B,Phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,35526,-0.0843476701285873,0.0365065170741979,-0.155900443594015,-0.0127948966631593,0.0208788252578976
PLA2G1B,Phospholipase A2,Diet and food preferences,X20703.Liking for porridge,35526,0.0664668016103665,0.0373074054090392,-0.00665571299135026,0.139589316212083,0.0748408256861793
PLA2G1B,Phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,35526,-0.0818137451892113,0.0367767850975339,-0.153896243980378,-0.00973124639804479,0.0261269751789538
PLA2G1B,Phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,35526,-0.0107739534422488,0.0371381325524743,-0.0835646932450983,0.0620167863606008,0.771741163200264
PLA2G1B,Phospholipase A2,Diet and food preferences,X20706.Liking for prawns,35526,-0.0937368012782402,0.0372411960396611,-0.166729545515976,-0.0207440570405045,0.0118485458335059
PLA2G1B,Phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,35526,0.0238395045267222,0.0372991497045437,-0.0492668288941835,0.0969458379476279,0.522742221680985
PLA2G1B,Phospholipase A2,Diet and food preferences,X20708.Liking for red meat,35526,-0.124366287789189,0.0369809977449126,-0.196849043369218,-0.0518835322091603,0.000773546826961839
PLA2G1B,Phospholipase A2,Diet and food preferences,X20709.Liking for red wine,35526,-0.20932079788441,0.0366274254150015,-0.281110551697813,-0.137531044071007,1.12482069404407e-08
PLA2G1B,Phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35526,0.0528960250327777,0.0377645974231967,-0.0211225859166878,0.126914635982243,0.161337126974835
PLA2G1B,Phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,35526,0.000866348246797769,0.0382753128610161,-0.0741532649607939,0.0758859614543894,0.981942092933697
PLA2G1B,Phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,35526,-0.0931446195689492,0.0364885236291094,-0.164662125882004,-0.0216271132558948,0.0107014747760857
PLA2G1B,Phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,35526,-0.0435234364496987,0.0377024363307905,-0.117420211658048,0.0303733387586507,0.248362663196622
PLA2G1B,Phospholipase A2,Diet and food preferences,X20714.Liking for salami,35526,-0.0916615739739977,0.0360901471303395,-0.162398262349463,-0.0209248855985322,0.0111046195888804
PLA2G1B,Phospholipase A2,Diet and food preferences,X20715.Liking for salmon,35526,-0.010684701511401,0.038031651698049,-0.085226738839577,0.063857335816775,0.778759605504969
PLA2G1B,Phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,35526,-0.0391079930785822,0.0367333564588219,-0.111105371737873,0.0328893855807087,0.287058551361482
PLA2G1B,Phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,35526,0.0151157063309012,0.036475404841561,-0.0563760871585583,0.0866074998203608,0.678582820581357
PLA2G1B,Phospholipase A2,Diet and food preferences,X20718.Liking for sardines,35526,-0.0451820019378118,0.0364700985147098,-0.116663395026643,0.0262993911510194,0.215415634593902
PLA2G1B,Phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),35526,-0.0898756885895239,0.0364617862519587,-0.161340789643363,-0.0184105875356848,0.013718376114053
PLA2G1B,Phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,35526,-0.0729929130019331,0.0367328005564329,-0.144989202092542,-0.000996623911324629,0.0469311681250316
PLA2G1B,Phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35526,-0.0640887682344905,0.0367173799754902,-0.136054832986451,0.00787729651747021,0.0809309385829101
PLA2G1B,Phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,35526,0.011787663180278,0.0367210723373958,-0.0601856386010179,0.0837609649615738,0.748212039576825
PLA2G1B,Phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,35526,-0.0710831333992886,0.0367255766349679,-0.143065263603826,0.000898996805248548,0.0529505183591939
PLA2G1B,Phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,35526,-0.0665808742263988,0.0365354698678956,-0.138190395167474,0.00502864671467654,0.0684255916341663
PLA2G1B,Phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,35526,-0.0464862601152581,0.0368380177570295,-0.118688774919036,0.0257162546885198,0.207006449346134
PLA2G1B,Phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,35526,0.0781296484293189,0.0367779009688154,0.00604496253044075,0.150214334328197,0.0336607064802483
PLA2G1B,Phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,35526,-0.0796422731035406,0.0371196480534221,-0.152396783288248,-0.00688776291883325,0.0319290337431374
PLA2G1B,Phospholipase A2,Diet and food preferences,X20728.Liking for spinach,35526,-0.0233275769492857,0.0372884304112505,-0.0964129005553366,0.0497577466567653,0.531590731775799
PLA2G1B,Phospholipase A2,Diet and food preferences,X20729.Liking for spirits,35526,-0.225175534893931,0.0366329077134394,-0.296976034012272,-0.153375035775589,8.16395950773448e-10
PLA2G1B,Phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,35526,-0.00903241911981469,0.0397323476050617,-0.0869078204257357,0.0688429821861063,0.820169870765841
PLA2G1B,Phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35526,0.013997513242256,0.0377947316912215,-0.060080160872538,0.0880751873570501,0.711123832747645
PLA2G1B,Phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,35526,0.215107943729858,0.0369549475620801,0.142676246508181,0.287539640951535,6.01040031418401e-09
PLA2G1B,Phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,35526,0.0516543972134183,0.0377005029949495,-0.0222385886566828,0.125547383083519,0.170674308471003
PLA2G1B,Phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,35526,0.122150976275259,0.0436761588742474,0.0365457048817338,0.207756247668784,0.00517051984775793
PLA2G1B,Phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,35526,0.0953802002917396,0.038390896285212,0.020134043572724,0.170626357010755,0.0129891613612057
PLA2G1B,Phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,35526,-0.0430004194177858,0.0363176538581203,-0.114183020979702,0.0281821821441299,0.236433747029593
PLA2G1B,Phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,35526,-0.0759828238955021,0.0367731446272936,-0.148058187364998,-0.00390746042600663,0.0388261125124006
PLA2G1B,Phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),35526,-0.0845445287076422,0.036655958381668,-0.156390207135712,-0.0126988502795729,0.0211038761571281
PLA2G1B,Phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,35526,-0.0523218377589257,0.0405344852360989,-0.13176942882168,0.0271257533038282,0.196799285453204
PLA2G1B,Phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,35526,-0.0584773272566445,0.0368675499470693,-0.1307377251529,0.0137830706396113,0.112733254023868
PLA2G1B,Phospholipase A2,Diet and food preferences,X20741.Liking for watching television,35526,0.057762978616754,0.0370909344332679,-0.0149352528724512,0.130461210105959,0.119418319912544
PLA2G1B,Phospholipase A2,Diet and food preferences,X20742.Liking for whisky,35526,-0.1340648949544,0.038094996139452,-0.208731087387726,-0.0593987025210745,0.000434458268004479
PLA2G1B,Phospholipase A2,Diet and food preferences,X20743.Liking for white bread,35526,-0.0430065534189303,0.0364658086492028,-0.114479538371368,0.0284664315335073,0.238276334643658
PLA2G1B,Phospholipase A2,Diet and food preferences,X20744.Liking for white rice,35526,-0.0110193084361953,0.0369598716293797,-0.0834606568297796,0.0614220399573889,0.765599720926798
PLA2G1B,Phospholipase A2,Diet and food preferences,X20745.Liking for white wine,35526,-0.163525017681686,0.0367685466266846,-0.235591369069988,-0.0914586662933843,8.77139187349362e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35526,0.0787239508306716,0.0371022221663177,0.00600359538468891,0.151444306276654,0.0338745394780106
PLA2G1B,Phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,35526,0.0847527044002701,0.0367082564093169,0.012804521838009,0.156700886962531,0.0209710547205169
PLA2G1B,Phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,35526,-0.0469146841182715,0.0382256729075852,-0.121837003017138,0.0280076347805954,0.219731536674518
PLA2G1B,Phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,35526,0.0694873831170249,0.0367787111430251,-0.00259889072330421,0.141573656957354,0.0588714694150129
PLA2G1B,Phospholipase A2,Physical measures,X21001.Body mass index (BMI),52337,-0.0820575302686642,0.0114633173169691,-0.104525632209924,-0.0595894283274048,8.36783628921433e-13
PLA2G1B,Phospholipase A2,Physical measures,X21002.Weight,52359,-0.0546281813402218,0.00668092685555542,-0.0677227979771104,-0.0415335647033332,3.03631386391307e-16
PLA2G1B,Phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33112,-0.0252033631447243,0.00525448474384681,-0.035502153242664,-0.0149045730467845,1.63948900455808e-06
PLA2G1B,Phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34881,0.0195229391971727,0.0393499995221878,-0.0576030598663154,0.0966489382606609,0.619808578096871
PLA2G1B,Phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34881,0.0105473443298109,0.0411243983224561,-0.070056476382203,0.0911511650418248,0.797589541397631
PLA2G1B,Phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34881,0.0544555604651781,0.040421380422974,-0.0247703451638509,0.133681466094207,0.177944514665695
PLA2G1B,Phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,34850,-0.0148672268213849,0.0375290997017398,-0.0884242622367949,0.0586898085940251,0.692000617474346
PLA2G1B,Phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34849,-0.0664404024387294,0.039955207193704,-0.144752608538389,0.0118718036609304,0.0963665656803479
PLA2G1B,Phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34841,-0.00688418060731945,0.0409220952122881,-0.0870914872234041,0.0733231260087652,0.86640819713896
PLA2G1B,Phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,34780,0.0318246552404691,0.0405653406059776,-0.0476834123472469,0.111332722828185,0.432747238223563
PLA2G1B,Phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,34812,-0.0641783085836791,0.0455020974114909,-0.153362419510201,0.0250058023428431,0.158436080576756
PLA2G1B,Phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34886,0.0213117631288227,0.040787159329501,-0.0586310691569992,0.101254595414645,0.601324683636271
PLA2G1B,Phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34881,0.0828670989834963,0.0410461483354559,0.00241664824600261,0.16331754972099,0.0435242407315015
PLA2G1B,Phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30304,-0.0736040946438468,0.0601821044825853,-0.191561019429714,0.0443528301420204,0.22136576134642
PLA2G1B,Phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34883,-0.0654424068580969,0.0431131989010866,-0.149944276704227,0.0190594629880329,0.129063131067986
PLA2G1B,Phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34881,0.0140322969527078,0.0612825820013919,-0.10608156377002,0.134146157675436,0.818891102864785
PLA2G1B,Phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34884,-0.0533685584425382,0.0487264149843569,-0.148872331811878,0.0421352149268013,0.273422495185262
PLA2G1B,Phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34882,0.185045206958997,0.119847800892319,-0.0498564827899489,0.419946896707943,0.122616635080624
PLA2G1B,Phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34884,0.091096098353174,0.0460218017921279,0.000893366840603302,0.181298829865745,0.0477944977526936
PLA2G1B,Phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34884,0.148017967235463,0.0478705749759103,0.0541916402826793,0.241844294188248,0.00199279065081895
PLA2G1B,Phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34633,0.0468467228367813,0.0430735694323357,-0.0375774732505967,0.131270918924159,0.276797002872123
PLA2G1B,Phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34884,0.0504797119770966,0.0428165345016261,-0.0334406956460905,0.134400119600284,0.238432757588121
PLA2G1B,Phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34885,-0.0509858060561317,0.0581969536307326,-0.165051835172368,0.0630802230601043,0.380999852429695
PLA2G1B,Phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34883,0.0248826549053465,0.0407727019384965,-0.0550318408941066,0.1047971507048,0.541690706359024
PLA2G1B,Phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34881,0.00986383749859963,0.0406520380121451,-0.0698141570052049,0.0895418320024041,0.808288292627019
PLA2G1B,Phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52096,0.0103365744613225,0.0245946693942322,-0.0378689775513727,0.0585421264740176,0.67428629071283
PLA2G1B,Phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,49372,0.00989914560950834,0.00307972330341843,0.00386288793480822,0.0159354032842085,0.00130926925383984
PLA2G1B,Phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47334,-0.0824504766565787,0.0278083689506672,-0.136954879799886,-0.027946073513271,0.00303034573969721
PLA2G1B,Phospholipase A2,Physical activities,X22032.IPAQ activity group,47307,0.0727979777059585,0.0266347412262379,0.0205938849025322,0.125002070509385,0.00627699476089477
PLA2G1B,Phospholipase A2,Physical activities,X22033.Summed days activity,47892,0.00624035855684243,0.00297829045207964,0.000402909270766329,0.0120778078429185,0.0361563644853171
PLA2G1B,Phospholipase A2,Physical activities,X22034.Summed minutes activity,47307,0.00346203765452684,0.00303395381385252,-0.0024845118206241,0.00940858712967778,0.253840931472822
PLA2G1B,Phospholipase A2,Physical activities,X22037.MET minutes per week for walking,46521,-0.000240147073741076,0.00297189521416276,-0.00606506169350008,0.00558476754601793,0.935596920774558
PLA2G1B,Phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,47307,0.00131700860498265,0.00310704819812162,-0.00477280586333574,0.00740682307330103,0.671658858833196
PLA2G1B,Phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,47307,0.0890327097701443,0.0266915587491508,0.0367172546218088,0.14134816491848,0.000852436529290173
PLA2G1B,Phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,46521,0.00405778636150948,0.0030613374524539,-0.00194243504530015,0.0100580077683191,0.185020510988285
PLA2G1B,Phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,46666,-0.00593330154342727,0.00354635800569716,-0.0128841632345937,0.00101756014773917,0.0943274340490436
PLA2G1B,Phospholipase A2,Working and living environment,X22501.Year ended full time education,31468,0.00664060074699376,0.0146893392800578,-0.0221505042419195,0.035431705735907,0.651231877592453
PLA2G1B,Phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,31418,0.0945655901638996,0.097241212061547,-0.0960271854767325,0.285158365804532,0.330840606600926
PLA2G1B,Phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50390,-0.152603019961472,0.0536742537536581,-0.257804557318642,-0.047401482604302,0.00447066013769177
PLA2G1B,Phospholipase A2,Physical measures,X23098.Weight,51976,-0.0531354149410439,0.00672753353118385,-0.0663213806621643,-0.0399494492199235,2.9322628633257e-15
PLA2G1B,Phospholipase A2,Physical measures,X23099.Body fat percentage,51954,-0.039783729256699,0.00652130378659895,-0.0525654846784329,-0.027001973834965,1.07064497329663e-09
PLA2G1B,Phospholipase A2,Physical measures,X23100.Whole body fat mass,51920,-0.0536680390403152,0.00619460189903007,-0.0658094587624141,-0.0415266193182162,4.80889056774123e-18
PLA2G1B,Phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51971,-0.0225954652814384,0.00575309920768428,-0.0338715397284996,-0.0113193908343772,8.60278287515828e-05
PLA2G1B,Phospholipase A2,Physical measures,X23102.Whole body water mass,51976,-0.0221695049812887,0.00575327405730461,-0.0334459221336057,-0.0108930878289716,0.000116760886778663
PLA2G1B,Phospholipase A2,Physical measures,X23104.Body mass index (BMI),51976,-0.0826972779360594,0.0115540070276786,-0.105343131710309,-0.0600514241618093,8.42030101711007e-13
PLA2G1B,Phospholipase A2,Physical measures,X23105.Basal metabolic rate,51974,-0.0292670948326172,0.00616677727238724,-0.0413539782864962,-0.0171802113787382,2.08570299579758e-06
PLA2G1B,Phospholipase A2,Physical measures,X23106.Impedance of whole body,51973,-0.00982170641449116,0.00473274211399345,-0.0190978809579183,-0.000545531871064004,0.0379708113232555
PLA2G1B,Phospholipase A2,Physical measures,X23107.Impedance of leg (right),51973,0.00020644532626005,0.0039044680026777,-0.00744631195898825,0.00785920261150834,0.957832577096028
PLA2G1B,Phospholipase A2,Physical measures,X23108.Impedance of leg (left),51972,1.89405290453373e-05,0.00387607111586458,-0.00757815885804924,0.00761603991613991,0.996101165146487
PLA2G1B,Phospholipase A2,Physical measures,X23109.Impedance of arm (right),51966,-0.0131144827462317,0.00474445721010336,-0.0224136188780342,-0.00381534661442907,0.00571050927100406
PLA2G1B,Phospholipase A2,Physical measures,X23110.Impedance of arm (left),51971,-0.0113653586615544,0.00473720159035867,-0.0206502737786574,-0.00208044354445145,0.0164386897871546
PLA2G1B,Phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51972,-0.0279414624756772,0.00808128663949854,-0.0437807842890943,-0.01210214066226,0.000545914848536822
PLA2G1B,Phospholipase A2,Physical measures,X23112.Leg fat mass (right),51971,-0.0510638846107196,0.00838041901961086,-0.0674895058891569,-0.0346382633322823,1.12086338704409e-09
PLA2G1B,Phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51971,-0.0288958646949352,0.00618776071342884,-0.0410238756932557,-0.0167678536966146,3.02823850199122e-06
PLA2G1B,Phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51970,-0.0296600042352217,0.00621143279330166,-0.041834412510093,-0.0174855959603504,1.80552063621314e-06
PLA2G1B,Phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51969,-0.0341712000667862,0.00835933499575632,-0.0505554966584686,-0.0177869034751038,4.36713032138421e-05
PLA2G1B,Phospholipase A2,Physical measures,X23116.Leg fat mass (left),51969,-0.0568070984781361,0.00870618169060227,-0.0738712145917166,-0.0397429823645557,6.91964226541197e-11
PLA2G1B,Phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51967,-0.0315235164589398,0.00641734404392386,-0.0441015107850305,-0.018945522132849,9.05485166924322e-07
PLA2G1B,Phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51966,-0.0312717088504287,0.00644191187690584,-0.0438978561291641,-0.0186455615716932,1.21390712518497e-06
PLA2G1B,Phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51966,-0.0494097797659889,0.00718908707133467,-0.0635003904258049,-0.035319169106173,6.42287671491648e-12
PLA2G1B,Phospholipase A2,Physical measures,X23120.Arm fat mass (right),51964,-0.0607812301089985,0.00701850148948703,-0.0745374930283931,-0.0470249671896039,4.95957839933061e-18
PLA2G1B,Phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51963,-0.0141273526942159,0.00575811917031262,-0.0254132662680286,-0.00284143912040314,0.0141546977278342
PLA2G1B,Phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51962,-0.0127375139984401,0.00576241022025506,-0.02403183803014,-0.0014431899667402,0.0270820406355385
PLA2G1B,Phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51958,-0.0473743662588019,0.00734601633107706,-0.061772558267713,-0.0329761742498909,1.14428263528449e-10
PLA2G1B,Phospholipase A2,Physical measures,X23124.Arm fat mass (left),51957,-0.0611497363151629,0.00698962617414626,-0.0748494036164896,-0.0474500690138362,2.27776100181997e-18
PLA2G1B,Phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51953,-0.0192019806136611,0.00584869913246531,-0.0306654309132931,-0.00773853031402909,0.00102790363093027
PLA2G1B,Phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51952,-0.0164779252849536,0.00587902241348477,-0.0280008092153837,-0.00495504135452344,0.00506903968216631
PLA2G1B,Phospholipase A2,Physical measures,X23127.Trunk fat percentage,51949,-0.0295581574202399,0.00467427092250398,-0.0387197284283477,-0.0203965864121321,2.59402815102625e-10
PLA2G1B,Phospholipase A2,Physical measures,X23128.Trunk fat mass,51945,-0.0419746014953443,0.00509520037743899,-0.0519611942351247,-0.0319880087555639,1.82546497925082e-16
PLA2G1B,Phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51939,-0.0174321945075146,0.00524117982271589,-0.0277049069600378,-0.00715948205499146,0.000882130397996662
PLA2G1B,Phospholipase A2,Physical measures,X23130.Trunk predicted mass,51937,-0.0171544522634688,0.00523342913636946,-0.0274119733707529,-0.00689693115618463,0.00104724015144883
PLA2G1B,Phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,40031,-0.0137795137763517,0.00396956308064412,-0.0215598574144142,-0.00599917013828925,0.000519311920175949
PLA2G1B,Phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40031,-0.00285954215990626,0.00385456824693334,-0.0104144959238956,0.00469541160408309,0.458184169732603
PLA2G1B,Phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40031,-0.0033629377083453,0.00387185335063696,-0.0109517702755938,0.00422589485890315,0.385100623245981
PLA2G1B,Phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,40031,0.00323547298579393,0.0038170764854209,-0.00424599692563104,0.0107169428972189,0.396655957868118
PLA2G1B,Phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40031,0.000447535050614405,0.00385092457088424,-0.0071002771083187,0.00799534720954751,0.907483622658876
PLA2G1B,Phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,40031,-0.00257682369795413,0.00381922709695426,-0.0100625088079845,0.00490886141207623,0.499877498325784
PLA2G1B,Phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,40031,-0.0367918288397454,0.00435556632123251,-0.0453287388293611,-0.0282549188501297,3.23763531432463e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,40031,-0.0185380381391962,0.00391149520919626,-0.0262045687492209,-0.0108715075291716,2.16204303410846e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,40031,-0.014691925225969,0.00397598781058523,-0.0224848613347161,-0.00689898911722197,0.000220470127662229
PLA2G1B,Phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,40031,-0.0227816547042527,0.00373177371398734,-0.0300959311836678,-0.0154673782248375,1.05293532542837e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,40031,-0.0309955134102611,0.00368782685974907,-0.0382236540553693,-0.0237673727651529,4.63793335261602e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40031,-0.0364958999189593,0.00392520265314085,-0.0441892971191154,-0.0288025027188033,1.61245827221574e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,40031,-0.0038509454059955,0.00385806949446847,-0.0114127616151537,0.00371087080316269,0.318219886629423
PLA2G1B,Phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,40031,-0.00246774169740355,0.00382225934393011,-0.00995937001150657,0.00502388661669947,0.518532164531823
PLA2G1B,Phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,40031,-0.0518229026658251,0.00408188154049424,-0.0598233904851938,-0.0438224148464564,9.33975119475581e-37
PLA2G1B,Phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,40031,-0.0153370106598878,0.00398384443470942,-0.0231453457519183,-0.00752867556785733,0.000118668591469521
PLA2G1B,Phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40031,0.00643420381239772,0.00381655996762959,-0.00104625372415628,0.0139146613489517,0.0918411498997533
PLA2G1B,Phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40031,-0.0039320950398567,0.00380511156613826,-0.0113901137094877,0.00352592362977429,0.301445385491956
PLA2G1B,Phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40031,-0.034093619877661,0.00434842535681026,-0.0426165335770091,-0.0255707061783129,4.76762654016771e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,40031,-0.00958865125207884,0.00393092941936765,-0.0172932729140394,-0.00188402959011824,0.0147270940348967
PLA2G1B,Phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40031,-0.000877707831529726,0.00383916896687358,-0.00840247900660194,0.00664706334354249,0.819167772220128
PLA2G1B,Phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,40031,0.00141742291086745,0.00386489209675479,-0.00615776559877195,0.00899261142050684,0.713815374906782
PLA2G1B,Phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,40031,-0.0433360214968189,0.00431610390601187,-0.0517955851526022,-0.0348764578410357,1.18610383715412e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40031,-0.0248842963076519,0.00382881954530969,-0.0323887826164589,-0.0173798099988449,8.31051650778779e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,40031,-0.00812653301087675,0.00389402636583329,-0.01575882468791,-0.000494241333843508,0.0369107208394452
PLA2G1B,Phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,40031,-0.00408677924229516,0.00381470434368561,-0.011563599755919,0.00339004127132864,0.284040358557616
PLA2G1B,Phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,40031,-0.0474879013433531,0.00417477086385608,-0.055670452236511,-0.0393053504501952,7.23687856269374e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40031,-0.0437748346745852,0.00393466096034606,-0.0514867701568634,-0.0360628991923069,1.19862128655456e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,40031,-0.000681390579010446,0.0038084885357199,-0.00814602810902145,0.00678324695100056,0.858007747174087
PLA2G1B,Phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,40031,0.00818491849392114,0.00382312178217142,0.000691599800865158,0.0156782371869771,0.0322970716718622
PLA2G1B,Phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,40031,-0.0462669094306326,0.00393354398875937,-0.053976655648601,-0.0385571632126643,8.24331506001871e-32
PLA2G1B,Phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40031,-0.00809292138726847,0.00418033873662947,-0.0162863853110622,0.00010054253652529,0.0528913891084326
PLA2G1B,Phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40031,0.00711069991990758,0.00381229079554271,-0.000361390039356133,0.0145827898791713,0.0621709163713856
PLA2G1B,Phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40031,-0.012890427529102,0.0044305781534623,-0.0215743607098881,-0.00420649434831592,0.00362589469396037
PLA2G1B,Phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,40019,-0.045314115710086,0.00387798740301043,-0.0529149710199865,-0.0377132604001856,2.03550603323021e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40019,0.000324246022579655,0.00419290341317307,-0.00789384466723955,0.00854233671239886,0.938360313350702
PLA2G1B,Phospholipase A2,NMR metabolomics,X23436.Total Cholines,40019,-0.0400521789078802,0.00394665884054062,-0.0477876302353398,-0.0323167275804205,3.97988007287868e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,40019,-0.0460465518782809,0.00393292843371916,-0.0537550916083704,-0.0383380121481913,1.5559346482606e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,40018,-0.0195899020555052,0.00407973180087999,-0.02758617638523,-0.0115936277257804,1.58684405588336e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,40031,0.00575793404579698,0.00383632335550131,-0.00176125973098558,0.0132771278225795,0.13340120010335
PLA2G1B,Phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,40031,-0.0494646636898919,0.00405460332148443,-0.0574116862000014,-0.0415176411797825,4.40840854347577e-34
PLA2G1B,Phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40031,0.0304985271635338,0.00383201094213532,0.0229877857169486,0.038009268610119,1.8503773146185e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,40019,-0.0307151789685875,0.00373024812676401,-0.038026465297045,-0.02340389264013,1.94638136304668e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,40019,0.0258744575706486,0.00413865511044608,0.0177626935541742,0.0339862215871229,4.15668195101858e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40019,-0.0206943238678488,0.0037954942852791,-0.0281334926669959,-0.0132551550687018,5.04406390474601e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40019,-0.0103362177538171,0.00379068220271542,-0.0177659548711394,-0.00290648063649492,0.00640317454364165
PLA2G1B,Phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40019,-0.013902170447851,0.00379351026208713,-0.0213374505615418,-0.00646689033416026,0.000248397186512667
PLA2G1B,Phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40019,-0.0266408701543939,0.00379596984157462,-0.0340809710438802,-0.0192007692649077,2.33677474871229e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,40019,-0.0437227332924516,0.00374297514873825,-0.0510589645839785,-0.0363865020009246,2.12479067714007e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,40019,0.00116991146754004,0.00381676328746424,-0.00631094457588986,0.00865076751096994,0.759213265208663
PLA2G1B,Phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,40019,-0.0118058353671903,0.00396861234127613,-0.0195843155560916,-0.00402735517828913,0.00293611232360054
PLA2G1B,Phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40019,-0.00667368832055199,0.00383980968544299,-0.0141997153040202,0.000852338662916271,0.082225316380118
PLA2G1B,Phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40019,0.0497119868827618,0.00389520761589547,0.0420773799556066,0.0573465938099169,4.01996889883583e-37
PLA2G1B,Phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40019,0.0495361537852035,0.00405338520673884,0.0415915187799954,0.0574807887904116,3.40185370098412e-34
PLA2G1B,Phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40019,-0.0117466581388617,0.00415574074897792,-0.0198919100068585,-0.00360140627086501,0.00471013558423258
PLA2G1B,Phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40019,-0.0663046219148451,0.00371518742266113,-0.0735863892632609,-0.0590228545664293,1.45218571694408e-70
PLA2G1B,Phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40019,0.059908366470253,0.00397814741543158,0.0521111975360071,0.0677055354044988,6.63772093796093e-51
PLA2G1B,Phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40019,0.00863388996206096,0.00401658397575454,0.000761385369582066,0.0165063945545399,0.031604801836348
PLA2G1B,Phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40019,0.0295921098850968,0.00414878080964057,0.0214604994982013,0.0377237202719923,1.02573080365196e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40017,0.0188028209890642,0.00380627869936322,0.0113425147383123,0.0262631272398161,7.89244445970112e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23460.Alanine,40027,-0.0124823629170481,0.00369804628982954,-0.019730533645114,-0.00523419218898222,0.0007388350779139
PLA2G1B,Phospholipase A2,NMR metabolomics,X23461.Glutamine,39981,0.00548940592443705,0.0036621191110647,-0.00168834753324976,0.0126671593821239,0.133901049783926
PLA2G1B,Phospholipase A2,NMR metabolomics,X23462.Glycine,40012,0.0397315264555233,0.00383000895809864,0.0322247088976499,0.0472383440133966,3.91559919268474e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23463.Histidine,40013,0.0131188522478669,0.00365511031117956,0.00595483603795499,0.0202828684577789,0.000332700666865819
PLA2G1B,Phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40020,-0.0131360547924508,0.00390147679243004,-0.0207829493056137,-0.0054891602792879,0.000761832794117034
PLA2G1B,Phospholipase A2,NMR metabolomics,X23465.Isoleucine,40029,-0.0135900642429943,0.00380564131692514,-0.0210491212241676,-0.00613100726182104,0.000356610339462363
PLA2G1B,Phospholipase A2,NMR metabolomics,X23466.Leucine,40030,-0.00904791079793759,0.00392746882347088,-0.0167457496919405,-0.00135007190393466,0.0212492361060009
PLA2G1B,Phospholipase A2,NMR metabolomics,X23467.Valine,40020,-0.0150328244498823,0.00388330730459453,-0.0226441067668876,-0.00742154213287707,0.00010875383782789
PLA2G1B,Phospholipase A2,NMR metabolomics,X23468.Phenylalanine,40027,0.00782725825063425,0.00369363299625202,0.000587737577980293,0.0150667789232882,0.0340953762686313
PLA2G1B,Phospholipase A2,NMR metabolomics,X23469.Tyrosine,40014,-0.0217757558923633,0.00376427932730038,-0.0291537433738721,-0.0143977684108546,7.39237576882686e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23470.Glucose,40003,-0.0410884451310619,0.0037572635979998,-0.0484526817831415,-0.0337242084789823,9.73053165640599e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23471.Lactate,40002,-0.00777931979748486,0.00370215857673928,-0.0150355506078938,-0.000523088987075872,0.0356307182656919
PLA2G1B,Phospholipase A2,NMR metabolomics,X23472.Pyruvate,39977,-0.0110459257211468,0.00366181943200028,-0.0182230918078673,-0.00386875963442623,0.00256099027454777
PLA2G1B,Phospholipase A2,NMR metabolomics,X23473.Citrate,40029,0.0227959261504586,0.00374279113554708,0.0154600555247863,0.0301317967761309,1.15018018225923e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,39776,-0.00850442564403591,0.00361758151251145,-0.0155948854085584,-0.00141396587951348,0.0187422396807854
PLA2G1B,Phospholipase A2,NMR metabolomics,X23475.Acetate,40017,0.00158924078909951,0.00370039096894167,-0.00566352551002616,0.00884200708822518,0.667580286844491
PLA2G1B,Phospholipase A2,NMR metabolomics,X23476.Acetoacetate,40031,-0.0204966125135885,0.00362487869217587,-0.0276013747502532,-0.0133918502769238,1.59009390101373e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23477.Acetone,40031,-0.015395998938179,0.00364291322076428,-0.022536108850877,-0.00825588902548099,2.38881420626694e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23478.Creatinine,39599,0.114013267008528,0.00448695751739639,0.105218830274431,0.122807703742625,1.25964131279845e-139
PLA2G1B,Phospholipase A2,NMR metabolomics,X23479.Albumin,40030,-0.00768224787157108,0.00375843125734599,-0.0150487731359692,-0.000315722607172932,0.0409693348425773
PLA2G1B,Phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,40031,0.0061048041444238,0.00393724078957212,-0.00161218780313756,0.0138217960919852,0.121034282250244
PLA2G1B,Phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40031,-0.0187429321310146,0.00395307510555354,-0.0264909593378995,-0.0109949049241296,2.14103464477084e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40031,-0.0191023400042976,0.00397090604166597,-0.0268853158459629,-0.0113193641626323,1.51853750926418e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40031,-0.0175459790609563,0.00397385386870939,-0.0253347326436267,-0.00975722547828588,1.01497771670825e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40031,-0.0156604353471262,0.00394521822758767,-0.0233930630731981,-0.0079278076210544,7.23432277690611e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40031,-0.0146199132874103,0.00396122512695754,-0.0223839145362471,-0.00685591203857354,0.000224323219383737
PLA2G1B,Phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40031,-0.0174940493171895,0.00391219375230812,-0.0251619490717134,-0.0098261495626656,7.81384435126196e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40031,-0.0224088993579455,0.00396236378213169,-0.0301751323709236,-0.0146426663449674,1.58078940851552e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40031,-0.012450505696973,0.00402727684542175,-0.0203439683139996,-0.00455704307994637,0.00199456704717392
PLA2G1B,Phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40031,-0.0127770590127367,0.00403268829601608,-0.0206811280729282,-0.00487298995254516,0.00153580210736798
PLA2G1B,Phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40031,-0.0101253866139015,0.00400531164984091,-0.0179757974475897,-0.00227497578021332,0.011481211032857
PLA2G1B,Phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40031,-0.00295845734577005,0.0039475934668971,-0.0106957405408884,0.00477882584934826,0.453607087827299
PLA2G1B,Phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40031,0.00184876655214254,0.00391128741079336,-0.00581735677301245,0.00951488987729753,0.636451667826562
PLA2G1B,Phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40031,-0.00764318562706472,0.00397572135310612,-0.0154355994791527,0.000149228225023279,0.0545648044508542
PLA2G1B,Phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40031,-0.0179482732768705,0.00406826205381849,-0.0259220669023548,-0.0099744796513863,1.03187374816531e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40031,-0.00834331544308995,0.00398549299591714,-0.0161548817150875,-0.000531749171092352,0.0363271105366126
PLA2G1B,Phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40031,-0.00850001972265843,0.00398998832089242,-0.0163203968316076,-0.000679642613709288,0.0331588504480758
PLA2G1B,Phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40031,-0.00820047744952437,0.00400979244509718,-0.0160596706419148,-0.000341284257133898,0.0408598995900849
PLA2G1B,Phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40031,0.000530762767525787,0.00392100614165694,-0.00715440927012181,0.00821593480517338,0.892325832824284
PLA2G1B,Phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40031,0.00713804858055657,0.00385648383326419,-0.000420659732641247,0.0146967568937544,0.0641990795715611
PLA2G1B,Phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40031,-0.00572298260459095,0.00399240048400783,-0.0135480875532463,0.00210212234406439,0.151743165780087
PLA2G1B,Phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40031,-0.0136573446456275,0.00401151133444774,-0.021519906861145,-0.0057947824301099,0.000664369021011247
PLA2G1B,Phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40031,0.00543744236349035,0.00381093723120267,-0.00203199460966689,0.0129068793366476,0.153657075632361
PLA2G1B,Phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40031,0.000887417427219924,0.00382574359778841,-0.00661104002444537,0.00838587487888521,0.816572434774473
PLA2G1B,Phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40031,0.00522327776367445,0.00380983778858773,-0.00224400430195751,0.0126905598293064,0.170394787787183
PLA2G1B,Phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40031,0.0159965356952817,0.00384438825921565,0.00846153470721903,0.0235315366833444,3.18481817951541e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40031,0.0205540750682382,0.00388812508183429,0.012933349907843,0.0281748002286334,1.26387428969276e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40031,0.00921862185709816,0.00380768350623068,0.00175556218488603,0.0166816815293103,0.0154863511524184
PLA2G1B,Phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40031,-0.00891350348227297,0.0039228617802707,-0.0166023125716036,-0.00122469439294239,0.0230878589785298
PLA2G1B,Phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40031,0.0037261062155485,0.0038265133320234,-0.00377385991521737,0.0112260723463144,0.330190206624126
PLA2G1B,Phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40031,0.00214223934854073,0.00381691430921281,-0.00533891269751639,0.00962339139459784,0.574635578847352
PLA2G1B,Phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40031,0.00780412511582544,0.00379112424564679,0.00037352159435773,0.0152347286372931,0.0395557203128811
PLA2G1B,Phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40031,0.0112153874566618,0.00379877913148543,0.00376978035895038,0.0186609945543733,0.00315801743764609
PLA2G1B,Phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40031,0.0111294969215293,0.00380572813844041,0.00367026977018612,0.0185887240728725,0.00345592529994909
PLA2G1B,Phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40031,0.0111120307649318,0.00379903885108018,0.00366591461681461,0.0185581469130489,0.00344980731561345
PLA2G1B,Phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40031,-0.00841241543683283,0.00386325800002323,-0.0159844011168784,-0.00084042975678729,0.0294543858322304
PLA2G1B,Phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40031,-0.00212971273953142,0.00382099931314231,-0.00961887139329035,0.00535944591422751,0.577281952225842
PLA2G1B,Phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40031,-0.00430212816552221,0.00381040128482432,-0.0117705146837779,0.00316625835273346,0.25889408869203
PLA2G1B,Phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40031,-0.00152016601356867,0.00378766277682691,-0.0089439850561494,0.00590365302901207,0.688170177503111
PLA2G1B,Phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40031,-9.56554491500434e-05,0.00395233189722712,-0.00784222596771521,0.00765091506941512,0.980691556915273
PLA2G1B,Phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40031,-0.000491869037539878,0.00400452225213681,-0.00834073265172802,0.00735699457664827,0.902244515618782
PLA2G1B,Phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40031,0.00117815790562537,0.0038388905741254,-0.00634606761966041,0.00870238343091115,0.758922967125253
PLA2G1B,Phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40031,-0.0135675959059252,0.00375198815864123,-0.020921492696862,-0.00621369911498835,0.000299974743489178
PLA2G1B,Phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,40031,-0.000485429882076016,0.00392125773026137,-0.0081710950333883,0.00720023526923627,0.901479577353138
PLA2G1B,Phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,40031,-0.0101589091338495,0.00401223941614773,-0.0180228983894991,-0.00229491987819997,0.0113514376294358
PLA2G1B,Phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,40031,-0.00349150428340096,0.00401198522357337,-0.0113549953216048,0.00437198675480285,0.384166617787715
PLA2G1B,Phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,40031,-0.00955253416587298,0.00403681312255467,-0.0174646878860801,-0.00164038044566582,0.0179759123831608
PLA2G1B,Phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40031,-0.0125108992107155,0.00402982683010657,-0.0204093597977244,-0.00461243862370666,0.00190881742069838
PLA2G1B,Phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,40031,-0.000731044068459201,0.00403905017944657,-0.00864758242017448,0.00718549428325608,0.856374510979152
PLA2G1B,Phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,40031,-0.0203335186897694,0.00369909233533807,-0.027583739667032,-0.0130832977125068,3.92387742969663e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40031,0.0100356180073025,0.00382707752879551,0.0025345460508633,0.0175366899637417,0.00874289029323577
PLA2G1B,Phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,40031,-0.00502062334853854,0.00384400318638996,-0.0125548695938629,0.00251362289678578,0.191539714751906
PLA2G1B,Phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,40031,-0.00378444731821627,0.00385770701737026,-0.011345553072262,0.00377665843582943,0.326602722037406
PLA2G1B,Phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,40031,-0.00330326271139576,0.00385037234253128,-0.0108499925027571,0.00424346707996554,0.390956343151344
PLA2G1B,Phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40031,-0.00405079017862965,0.00382849981334993,-0.0115546498127955,0.00345306945553621,0.290042980842477
PLA2G1B,Phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40031,-0.00104472383963553,0.00391553660595397,-0.00871917558730531,0.00662972790803425,0.789615018440315
PLA2G1B,Phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,40031,-0.0244214224225955,0.00370937935915686,-0.0316918059665429,-0.017151038878648,4.73024492612713e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40031,0.00409347340837592,0.00380910600362426,-0.00337237435872764,0.0115593211754795,0.282545417153964
PLA2G1B,Phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40031,-0.00371321458017491,0.00378840630740335,-0.0111384909426855,0.00371206178233566,0.32702568422111
PLA2G1B,Phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40031,-0.00271067547106936,0.00378044953652458,-0.0101203565626575,0.00469900562051882,0.473369248662359
PLA2G1B,Phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40031,-0.00235423109175221,0.00379045805457242,-0.00978352887871414,0.00507506669520973,0.534546472537797
PLA2G1B,Phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40031,-0.00427839823123657,0.00379648158350108,-0.0117195021348987,0.00316270567242555,0.25978554340651
PLA2G1B,Phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40031,0.00327412184262778,0.00378936769028121,-0.0041530388303234,0.0107012825155789,0.387585026686325
PLA2G1B,Phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40031,-0.020300045044213,0.00376285679434264,-0.0276752443611245,-0.0129248457273014,6.95456940962884e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40031,0.00714668312636771,0.00382258974550312,-0.000345592774818398,0.0146389590275538,0.0615585572122094
PLA2G1B,Phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,40031,0.00136249635978924,0.00381297198541574,-0.00611092873162561,0.00883592145120408,0.720848046868548
PLA2G1B,Phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,40031,0.00416513079566493,0.00381732641097808,-0.00331682896985211,0.011647090561182,0.275239843759099
PLA2G1B,Phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,40031,0.00236605760918759,0.00380882887106691,-0.00509924697810355,0.00983136219647872,0.534474530271112
PLA2G1B,Phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40031,-0.000787950218793409,0.00381101046531802,-0.00825753073081672,0.0066816302932299,0.836202831187749
PLA2G1B,Phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40031,0.0105811239919503,0.00379739153808109,0.00313823657731138,0.0180240114065892,0.00533560281382706
PLA2G1B,Phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,40031,-0.0156083193201004,0.00381408061772166,-0.0230839173308348,-0.00813272130936591,4.29208596770475e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40031,-0.00226111092287723,0.00446495094981829,-0.0110124147845211,0.00649019293876662,0.612573384379969
PLA2G1B,Phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40031,0.000599943309535894,0.00447821619897498,-0.00817736044045507,0.00937724705952686,0.893428549517372
PLA2G1B,Phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40031,-8.90893583717651e-05,0.00442761376596921,-0.00876721233967142,0.00858903362292789,0.983946854455459
PLA2G1B,Phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40031,0.00512183361615534,0.00454533174496856,-0.00378701660398303,0.0140306838362937,0.259829461348417
PLA2G1B,Phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40031,0.00453716715367705,0.00460000703941558,-0.00447884664357748,0.0135531809509316,0.32398145869148
PLA2G1B,Phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40031,0.00650843193978295,0.00427717616132487,-0.00187483333641381,0.0148916972159797,0.128112437424128
PLA2G1B,Phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40031,-0.0160818482302547,0.00363143597899915,-0.023199462749093,-0.00896423371141634,9.55088519257319e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40031,-0.0190776328075145,0.00457157281028673,-0.0280379155156765,-0.0101173500993526,3.02052770848216e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,40031,-0.0236709076940431,0.00450235122807553,-0.0324955161010711,-0.0148462992870151,1.47920801009784e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,40031,-0.0300702502463204,0.00440588129339034,-0.0387057775813654,-0.0214347229112753,9.10326587135828e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,40031,-0.0131339511997624,0.00461199022492057,-0.0221734520406067,-0.00409445035891803,0.00440803127556336
PLA2G1B,Phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40031,-0.0102647062308068,0.00462117515834982,-0.0193222095411724,-0.00120720292044113,0.026348987147332
PLA2G1B,Phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40031,-0.021687673907042,0.00454922373175778,-0.0306041524212872,-0.0127711953927967,1.88304030869761e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,40031,-0.0285841591634468,0.00366108572695938,-0.0357598871882872,-0.0214084311386064,6.18581029456792e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40031,-0.0504148932676255,0.00400756345722224,-0.0582697176437811,-0.0425600688914699,4.01917961322759e-36
PLA2G1B,Phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40031,-0.0534725907686736,0.00393936377002005,-0.0611937437579129,-0.0457514377794343,9.68152752664739e-42
PLA2G1B,Phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40031,-0.0564024268640533,0.00387044774555226,-0.0639885044453357,-0.0488163492827709,8.43203537225375e-48
PLA2G1B,Phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40031,-0.0466066149486285,0.00407215511520289,-0.0545880389744261,-0.0386251909228308,3.24887279955549e-30
PLA2G1B,Phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40031,-0.0451986031612636,0.0040650232525493,-0.0531660487362602,-0.037231157586267,1.28902966796883e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40031,-0.0507301586735051,0.00408012158419163,-0.0587271969785207,-0.0427331203684895,2.49412249969956e-35
PLA2G1B,Phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40031,-0.0359696387400653,0.00369675413825395,-0.043215276851043,-0.0287240006290875,2.58433078706009e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40031,-0.0383360919408754,0.00366379070353378,-0.0455171217198017,-0.0311550621619492,1.53324130729899e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,40031,-0.0498256378873991,0.00367153548617944,-0.0570218474403108,-0.0426294283344874,1.00984700926364e-41
PLA2G1B,Phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,40031,-0.0550127005657103,0.00367231704516291,-0.0622104419742296,-0.047814959157191,2.14845856344228e-50
PLA2G1B,Phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,40031,-0.0379770747242742,0.00366000942720924,-0.0451506932016043,-0.0308034562469441,3.81505384941852e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40031,-0.0339201716276443,0.00365008180780577,-0.0410743319709436,-0.026766011284345,1.68725164842097e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40031,-0.0448699746032616,0.0037133123932592,-0.0521480668940496,-0.0375918823124736,1.79862067309462e-33
PLA2G1B,Phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,40031,-0.0254576848235147,0.00398532969197471,-0.0332689310197851,-0.0176464386272442,1.72829861139745e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39264,0.0130804043711368,0.00370408341506248,0.00582040087761432,0.0203404078646592,0.000414656732333437
PLA2G1B,Phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39264,0.0203809750700424,0.00369898384716771,0.0131309667295937,0.0276309834104911,3.6482702074375e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39264,0.0184293938837761,0.00366402082744768,0.0112479130619786,0.0256108747055735,4.96442039070178e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39264,0.0194599061818126,0.00376471589945508,0.0120810630188807,0.0268387493447446,2.38262437058517e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39264,-0.0198035963741328,0.00362858163508485,-0.026915616378899,-0.0126915763693665,4.89881141423614e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39841,0.0245770283991903,0.00360705876151754,0.0175071932266159,0.0316468635717647,9.85905082088358e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39841,0.0353819033842977,0.00402394222289825,0.0274949766274171,0.0432688301411782,1.6044812956214e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39841,0.0327781373297515,0.0040094055257595,0.0249197024992629,0.0406365721602401,3.17058052677128e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39841,0.0359057035508734,0.00385320879664031,0.0283534143094584,0.0434579927922884,1.33207680788026e-20
PLA2G1B,Phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39841,-0.0375543553582657,0.00390526551568453,-0.0452086757690074,-0.029900034947524,7.81643977558678e-22
PLA2G1B,Phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40027,0.00520828914417059,0.00393270205209766,-0.00249980687794082,0.012916385166282,0.185404272049834
PLA2G1B,Phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40027,0.038429170999028,0.00378590582525617,0.0310087955815259,0.0458495464165301,3.890934033983e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40027,0.041351904971733,0.00394601011922074,0.0336177251380603,0.0490860848054056,1.29744268151209e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40027,0.0260026509335131,0.00369479157702709,0.01876085944254,0.0332444424244862,2.03359795383533e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40027,-0.0341716609738565,0.00363623481949784,-0.0412986812200722,-0.0270446407276407,6.3156471158754e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40031,0.0229092767432491,0.00398558188063865,0.0150975362571974,0.0307210172293009,9.19119892018062e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40031,0.0286427375979778,0.00414831160827959,0.0205120468457498,0.0367734283502058,5.21910101322018e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40031,0.0276779986449085,0.00416195346049582,0.0195205698623367,0.0358354274274803,3.01985720258419e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40031,0.0289964091910968,0.00407133001348095,0.0210166023646741,0.0369762160175194,1.10772924029373e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40031,-0.0283585398647177,0.00412385249286039,-0.036441290750724,-0.0202757889787113,6.34925081500968e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40031,0.0209638264672239,0.00395902519696352,0.0132041370811754,0.0287235158532724,1.2044179978818e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40031,0.0246582794828819,0.00383331393278588,0.0171449841746215,0.0321715747911422,1.28938309251457e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40031,0.0266574511361288,0.00372839308120953,0.0193498006969581,0.0339651015752994,9.05883551217656e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40031,0.0185098353369076,0.00398974306356834,0.0106899389323136,0.0263297317415015,3.52237952607119e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40031,-0.0239405874770952,0.003872536699346,-0.0315307594078133,-0.016350415546377,6.47534718493978e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40031,0.0221679551504664,0.00386864747427932,0.0145854061008789,0.0297505042000539,1.02124420204088e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40031,0.010558811223695,0.00407548201262679,0.00257086647894648,0.0185467559684435,0.00958355006422349
PLA2G1B,Phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40031,0.00609970870945641,0.00412159146521263,-0.00197861056236034,0.0141780279812732,0.13890869898285
PLA2G1B,Phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40031,0.0320357410546674,0.00370668550535975,0.0247706374641623,0.0393008446451725,5.99712960895498e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40031,-0.0170516676687671,0.00403562256046244,-0.0249614878872734,-0.00914184745026069,2.3994308207598e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40031,0.0371549862436866,0.00372054291033483,0.0298627221394304,0.0444472503479429,2.04281534207784e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40031,-0.00535567647298262,0.00390422205922447,-0.0130079517090626,0.00229659876309734,0.170155533286201
PLA2G1B,Phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40031,-0.0208415071695034,0.00384949715549432,-0.0283865215942723,-0.0132964927447346,6.24812240631682e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40031,0.0316714392147946,0.00382150704463157,0.0241812854073167,0.0391615930222725,1.24448918834392e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40031,-0.0119714190250721,0.00394377074680084,-0.0197012096888018,-0.0042416283613425,0.00240498291308868
PLA2G1B,Phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40031,0.0105530538686667,0.00372601010511764,0.00325007406263617,0.0178560336746973,0.00462764205699865
PLA2G1B,Phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40031,0.0168546939502841,0.00390847379181086,0.00919408531833483,0.0245153025822334,1.62487753701226e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40031,0.00687145246956907,0.00367977496242467,-0.000340906456783282,0.0140838113959214,0.0618698682332702
PLA2G1B,Phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40031,0.011953802517145,0.00413079841479374,0.00385743762414924,0.0200501674101407,0.00381090196864835
PLA2G1B,Phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40031,-0.021657905512918,0.00382223040521877,-0.0291494771071468,-0.0141663339186892,1.48399835258532e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40031,0.00579452513392986,0.00369253896183597,-0.00144285123126865,0.0130319014991284,0.116608735508555
PLA2G1B,Phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40031,0.0155889149187373,0.00385542107641976,0.0080322896089546,0.0231455402285201,5.29313601593376e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40031,-0.0044536303791039,0.00382444480145339,-0.0119495421899525,0.00304228143174475,0.244231801625006
PLA2G1B,Phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40031,0.0192265221574428,0.00400410577184633,0.011378474844624,0.0270745694702616,1.5873105001228e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40031,-0.0213970248225654,0.00373774256881384,-0.0287230002574405,-0.0140710493876903,1.05525870127983e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40031,0.0110437771843301,0.00377577974678456,0.00364324888063241,0.0184443054880279,0.00345045784069281
PLA2G1B,Phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40031,0.00968809780252506,0.00372239360845133,0.00239220632996045,0.0169839892750897,0.00925900119544053
PLA2G1B,Phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40031,-0.0096870240291211,0.00378170083676909,-0.0170991576691885,-0.00227489038905368,0.01042954342297
PLA2G1B,Phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40031,0.023123845579687,0.00381115176310635,0.0156539881239986,0.0305937030353755,1.32881264145507e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40031,-0.0210771016322189,0.00383348062051516,-0.0285907236484286,-0.0135634796160092,3.89580232548889e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40026,-0.00664149986478081,0.00420138430712431,-0.0148762131067445,0.00159321337718283,0.113945975715023
PLA2G1B,Phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40026,0.0179991736452135,0.00385562805087731,0.010442142665494,0.025556204624933,3.06162849831224e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40026,0.0124253419340542,0.00367586984452905,0.00522063703877727,0.0196300468293311,0.000725924431240301
PLA2G1B,Phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40026,0.0121677774215184,0.00443489765440764,0.00347537801887942,0.0208601768241574,0.00608284945427567
PLA2G1B,Phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40026,-0.0132271657239018,0.00410765506761933,-0.0212781696564357,-0.00517616179136795,0.00128387603521673
PLA2G1B,Phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40031,-0.0483243386112949,0.00411841422622455,-0.056396430494695,-0.0402522467278948,1.1505282218287e-31
PLA2G1B,Phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40031,0.0341433571725874,0.00420790067174472,0.0258958718559677,0.042390842489207,5.24249549358799e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40031,0.036859448155674,0.00406107520261997,0.0288997407585389,0.0448191555528092,1.25049996778947e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40031,-0.00099974481990235,0.00414482872792107,-0.00912360912662765,0.00712411948682295,0.80940090074249
PLA2G1B,Phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40031,-0.0092319225665931,0.00398866007758236,-0.0170496963186545,-0.00141414881453167,0.0206504555606085
PLA2G1B,Phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40031,-0.0157214025614707,0.00416641923359818,-0.0238875842593231,-0.00755522086361824,0.000161637995667974
PLA2G1B,Phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40031,0.0114504278946953,0.00408123433560962,0.00345120859690049,0.0194496471924902,0.00502785140340771
PLA2G1B,Phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40031,0.0178781894331401,0.00390113226171954,0.0102319702001698,0.0255244086661104,4.62176464269259e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40031,-0.0268103629812283,0.00439821358934651,-0.0354308616163475,-0.0181898643461092,1.11405851679465e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40031,-0.00813263319566106,0.00396697341695273,-0.0159079010928884,-0.000357365298433709,0.040372213873022
PLA2G1B,Phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40031,-0.0411515041533463,0.00369522941720778,-0.0483941538110735,-0.033908854495619,1.06108330020511e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40031,0.0290065046284644,0.00368841431127433,0.0217772125783667,0.0362357966785621,3.94714124248769e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40031,0.0255764064717758,0.00362441236711696,0.0184725582322265,0.032680254711325,1.77417298401676e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40031,0.0113005275957557,0.00402217304008776,0.00341706843718367,0.0191839867543277,0.00496691654296812
PLA2G1B,Phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40031,-0.00196836865143319,0.00406063870633224,-0.00992722051584437,0.005990483212978,0.627864795705183
PLA2G1B,Phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51996,0.00295814314028932,0.00313867146677379,-0.00319365293458731,0.00910993921516595,0.34595372461427
PLA2G1B,Phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51996,0.000917666976040039,0.00306921034353456,-0.00509798529728771,0.00693331924936778,0.764948945281895
PLA2G1B,Phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50014,-0.00121005800854612,0.00294688172713596,-0.00698594619373261,0.00456583017664037,0.681352212255546
PLA2G1B,Phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50014,0.000892736426332214,0.00318368242455096,-0.00534728112578766,0.00713275397845209,0.779165174563453
PLA2G1B,Phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50014,0.00171256935093378,0.00316774844618373,-0.00449621760358634,0.0079213563054539,0.588769522853662
PLA2G1B,Phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50014,6.95574065202215e-05,0.00292319077329002,-0.00565989650912823,0.00579901132216867,0.981016287479335
PLA2G1B,Phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51996,0.0239879619263375,0.0527737906008732,-0.079448667651374,0.127424591504049,0.649441490935645
PLA2G1B,Phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51996,-0.00309106704365052,0.00274189921651683,-0.00846518950802349,0.00228305542072246,0.259606153644832
PLA2G1B,Phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51996,0.00140577324979695,0.00277148173475602,-0.00402633095032486,0.00683787744991876,0.611998797818782
PLA2G1B,Phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51996,-0.00350688914803785,0.00280412785376472,-0.0090029797414167,0.00198920144534101,0.211084751549133
PLA2G1B,Phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51996,-0.0469499032956832,0.0366004264594031,-0.118686739156113,0.0247869325647469,0.199583481430854
PLA2G1B,Phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51996,-0.026010155888742,0.035471663369078,-0.095534616092135,0.043514304314651,0.463402468975618
PLA2G1B,Phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51996,0.00228497238267633,0.00314721235455132,-0.00388356383224425,0.00845350859759691,0.467826068835748
PLA2G1B,Phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51996,0.00158783533831239,0.00314607278759459,-0.004578467325373,0.00775413800199778,0.61377074443866
PLA2G1B,Phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51996,0.00155746702631124,0.00311420590260713,-0.00454637654279873,0.00766131059542121,0.616996672819379
PLA2G1B,Phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51947,0.000171255860492638,0.00302109392794256,-0.00575008823827479,0.00609259995926006,0.954795168027047
PLA2G1B,Phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51996,-0.0032660922279202,0.00274711391488629,-0.00865043550109734,0.00211825104525694,0.234482106827091
PLA2G1B,Phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51996,-0.00328995815080146,0.0027465356331188,-0.00867316799171432,0.00209325169011139,0.230982610375076
PLA2G1B,Phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51996,-0.00326273685167888,0.00274713298074233,-0.00864711749393384,0.00212164379057609,0.234966382788509
PLA2G1B,Phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51996,-0.00327457628399337,0.00274678304756034,-0.00865827105721163,0.0021091184892249,0.233212649969783
PLA2G1B,Phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51996,-0.00327357019562381,0.00274685266188752,-0.00865740141292335,0.00211026102167574,0.233368119597721
PLA2G1B,Phospholipase A2,Health and medical history,X2405.Number of children fathered,36426,-0.0484042505849806,0.039047298039475,-0.124936954742352,0.0281284535723903,0.215134969079416
PLA2G1B,Phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48798,-0.00361239753686174,0.00325324449370794,-0.0099887567445293,0.00276396167080583,0.266838086229736
PLA2G1B,Phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48798,0.0063439077744958,0.00296803858026572,0.000526552157174977,0.0121612633918166,0.0325745625844641
PLA2G1B,Phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",48798,-0.0022195552681122,0.00289801510296449,-0.0078996648699226,0.0034605543336982,0.443750138648906
PLA2G1B,Phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48798,-0.00127848764507764,0.00307385123632945,-0.00730323606828336,0.00474626077812808,0.677469399825234
PLA2G1B,Phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48798,0.00373990939719191,0.00300375476478126,-0.00214744994177937,0.00962726873616319,0.213114727789154
PLA2G1B,Phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",48798,0.00191450159500581,0.00290868427211805,-0.00378651957834557,0.00761552276835719,0.510414462256798
PLA2G1B,Phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52097,-0.00484301837120134,0.00310058441489981,-0.010920163824405,0.00123412708200229,0.118306374448316
PLA2G1B,Phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52097,-0.00479031555981237,0.00292512275489563,-0.0105235561594078,0.000942925039783059,0.101506705290679
PLA2G1B,Phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52097,0.000682536211734482,0.00279885024167526,-0.00480321026194902,0.00616828268541798,0.807338643514936
PLA2G1B,Phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28740,-0.0278157408991594,0.0600126966863481,-0.145440626404402,0.089809144606083,0.643028405493176
PLA2G1B,Phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,35772,-0.030931089564358,0.0375262978162722,-0.104482633284251,0.0426204541555354,0.409813441372301
PLA2G1B,Phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),39164,-0.0285564776505212,0.0334411598246678,-0.09410115090687,0.0369881956058276,0.393156014351401
PLA2G1B,Phospholipase A2,Health and medical history,X2734.Number of live births,39646,-0.0330016419782961,0.0320930605745686,-0.0959040407044505,0.0299007567478583,0.303819397548218
PLA2G1B,Phospholipase A2,Health and medical history,X2744.Birth weight of first child,35701,-0.0325900909671967,0.0373574179062011,-0.105810630063351,0.0406304481289575,0.383015498625436
PLA2G1B,Phospholipase A2,Health and medical history,X2754.Age at first live birth,33661,0.0149843114591694,0.00448801001599533,0.00618781182781859,0.0237808110905203,0.000844721358511012
PLA2G1B,Phospholipase A2,Health and medical history,X2764.Age at last live birth,33639,0.00977026974932014,0.00449710523102273,0.000955943496515593,0.0185845960021247,0.029836732846103
PLA2G1B,Phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,37341,0.0123260963715899,0.00452935165783047,0.00344856712224213,0.0212036256209376,0.00650930318957669
PLA2G1B,Phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,36133,0.009659108761863,0.00400858650827802,0.00180227920563807,0.0175159383180879,0.0159844367966914
PLA2G1B,Phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,29404,0.00471295746604921,0.00611526446427022,-0.00727296088392042,0.0166988758160188,0.440925064415743
PLA2G1B,Phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36672,0.0710412605811483,0.0442429108693684,-0.0156748447228138,0.15775736588511,0.108362410484176
PLA2G1B,Phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36667,0.0851845286163922,0.0489947969934322,-0.0108452734907349,0.181214330723519,0.0821213690998764
PLA2G1B,Phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36689,0.0319682395631888,0.0502802638636263,-0.0665810776095188,0.130517556735896,0.524917510888041
PLA2G1B,Phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36659,0.0463322501836785,0.0489654820547421,-0.049640094643616,0.142304595010973,0.344052880942397
PLA2G1B,Phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36699,-0.0835679556171865,0.0459205472127699,-0.173572228154215,0.00643631691984246,0.0688069635880652
PLA2G1B,Phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36723,-0.0217010957853304,0.0510537396681525,-0.121766425534909,0.0783642339642484,0.670797289572412
PLA2G1B,Phospholipase A2,Mental health,X28741.Difficulty learning a new task,36626,-0.00319561038137735,0.0576872517519076,-0.116262623815116,0.109871403052362,0.95582430000457
PLA2G1B,Phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,36182,0.0685195200472343,0.0552630714637283,-0.0397961000216731,0.176835140116142,0.215043781010088
PLA2G1B,Phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36634,0.0574372895876471,0.0475341944955613,-0.0357297316236531,0.150604310798947,0.226940329591092
PLA2G1B,Phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36721,-0.0437057172639067,0.0651128933090248,-0.171326988149595,0.0839155536217818,0.502086176757951
PLA2G1B,Phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29252,-0.0393477837232609,0.0591232123930843,-0.155229280013706,0.0765337125671842,0.505745309682428
PLA2G1B,Phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,29407,-0.0205102990859884,0.00736661172094574,-0.034948858059042,-0.00607174011293473,0.00538377538662828
PLA2G1B,Phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35322,-0.00364212743156258,0.00858531057832854,-0.0204693361650865,0.0131850813019614,0.671407648908473
PLA2G1B,Phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35322,-0.00366494112632713,0.00922045458748361,-0.021737032117795,0.0144071498651407,0.691021346567034
PLA2G1B,Phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35322,0.0321543045842729,0.0311766812467889,-0.0289519906594334,0.0932605998279793,0.302394956227621
PLA2G1B,Phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35322,-0.0102393255620674,0.0305019933061638,-0.0700232324421484,0.0495445813180136,0.737108036552807
PLA2G1B,Phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35322,-0.0410755540272424,0.0328633113502425,-0.105487644273718,0.023336536219233,0.211364920695915
PLA2G1B,Phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35322,0.0577390778411565,0.0278731334451693,0.00310773628862469,0.112370419393688,0.0383348089777571
PLA2G1B,Phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35322,-0.0162135935128686,0.0127610658661537,-0.0412252826105299,0.00879809558479276,0.203913978780342
PLA2G1B,Phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35322,-0.0196136006413121,0.0234624486275956,-0.0655999999513995,0.0263727986687753,0.403196460623969
PLA2G1B,Phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35247,-0.0617898687863493,0.0507681310616534,-0.16129540566719,0.0377156680944914,0.223591574897874
PLA2G1B,Phospholipase A2,Mental health,X29003.Recent feelings of depression,35243,-0.0504768614953168,0.0490434815494985,-0.146602085332334,0.0456483623417004,0.303395022966384
PLA2G1B,Phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35254,-0.0141421096753143,0.0403119518742284,-0.093153535348802,0.0648693159981734,0.725732284879213
PLA2G1B,Phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35260,-0.0394814873561591,0.0408705420112812,-0.11958774969827,0.040624774985952,0.334058019088606
PLA2G1B,Phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35262,-0.0621036738609777,0.05379333025581,-0.167538601162365,0.0433312534404099,0.248324967972099
PLA2G1B,Phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35225,0.0266070910683338,0.0527300402582012,-0.0767437878377406,0.129957969974408,0.613856085849661
PLA2G1B,Phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35260,0.0113029040715945,0.0524974976627019,-0.0915921913473012,0.11419799949049,0.82953441833924
PLA2G1B,Phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35251,0.045386740501654,0.092900630403802,-0.136698495089798,0.227471976093106,0.62516867726082
PLA2G1B,Phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35186,-0.0341763473155755,0.101943747369011,-0.233986092158836,0.165633397527685,0.737444892805887
PLA2G1B,Phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,32818,0.0462952154112026,0.0171669258916635,0.0126480406635422,0.079942390158863,0.00701469977730482
PLA2G1B,Phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32818,-0.00256634100899044,0.0303035908987818,-0.0619613791706028,0.0568286971526219,0.932511577936738
PLA2G1B,Phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32818,0.0351663996093282,0.0167991149713566,0.00224013426546922,0.0680926649531872,0.0363461196384476
PLA2G1B,Phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32818,0.0215106730298347,0.0483253594901414,-0.0732070315708425,0.116228377630512,0.656242460373679
PLA2G1B,Phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32818,0.0181512734014599,0.0289648198748252,-0.0386197735531975,0.0749223203561173,0.530894037941437
PLA2G1B,Phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32818,0.0311830870378966,0.0311393567149089,-0.0298500521233248,0.092216226199118,0.316658414355204
PLA2G1B,Phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32818,0.027437409398334,0.0351801383708261,-0.0415156618084852,0.0963904806051532,0.435463324758776
PLA2G1B,Phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32818,0.0532182791041165,0.0431260410416403,-0.0313087613374985,0.137745319545732,0.217228845224759
PLA2G1B,Phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32818,-0.00878909030360154,0.0342100886773054,-0.0758408641111201,0.058262683503917,0.797250169989852
PLA2G1B,Phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32818,0.0245301181941054,0.017337304202235,-0.00945099804227516,0.0585112344304859,0.15713990962072
PLA2G1B,Phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32818,0.0248505669210102,0.0254072284787623,-0.0249476008973639,0.0746487347393843,0.32805601554786
PLA2G1B,Phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32818,-0.0350903364491742,0.0397819702368111,-0.113062998113324,0.0428823252149756,0.377764606729357
PLA2G1B,Phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32818,-0.0170144034181125,0.0496538281310443,-0.114335906554959,0.0803070997187344,0.73186195441832
PLA2G1B,Phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32818,0.0216242582509637,0.0303852629348746,-0.0379308571013906,0.081179373603318,0.476688125754865
PLA2G1B,Phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32818,0.00170162591017028,0.0514234037539959,-0.0990882454476616,0.102491497268002,0.973603159329631
PLA2G1B,Phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32818,-0.084051487016831,0.0496557079273519,-0.181376674554441,0.0132737005207787,0.0905501575900096
PLA2G1B,Phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32818,-0.00153169041891989,0.0264941960632561,-0.0534603147029019,0.0503969338650622,0.953899429803757
PLA2G1B,Phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32818,-0.0286119192545621,0.0259233116265445,-0.0794216100425893,0.0221977715334651,0.269746913361527
PLA2G1B,Phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32818,0.00758647315030033,0.0370869111191364,-0.065103872643207,0.0802768189438076,0.837921092014093
PLA2G1B,Phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35081,-0.0303521974111777,0.0470178151434914,-0.122507115092421,0.0618027202700655,0.518586139527587
PLA2G1B,Phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35086,0.0109207684322496,0.04922883209577,-0.0855677424754596,0.107409279339959,0.824444937437153
PLA2G1B,Phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35079,0.000603064842923594,0.0451147841663188,-0.0878219121230612,0.0890280418089084,0.989334957894387
PLA2G1B,Phospholipase A2,Mental health,X29061.Recent trouble relaxing,35085,-0.0401317599643508,0.0473222399106946,-0.132883350189312,0.0526198302606105,0.396426629739607
PLA2G1B,Phospholipase A2,Mental health,X29062.Recent restlessness,35089,-0.0397611849993547,0.0664012077644659,-0.169907552217708,0.0903851822189985,0.549316919457123
PLA2G1B,Phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,35071,-0.0262651107662553,0.0481084731322469,-0.120557718105459,0.0680274965729485,0.585107030775271
PLA2G1B,Phospholipase A2,Mental health,X29064.Recent feelings of foreboding,35062,-0.0559476360974899,0.0548467959007989,-0.163447356063056,0.051552083868076,0.307716734604301
PLA2G1B,Phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32818,-0.0031081866079305,0.0173531946732496,-0.0371204481674998,0.0309040749516388,0.857852851103167
PLA2G1B,Phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32818,0.0109270124641764,0.0285854378683279,-0.0451004457577463,0.066954470686099,0.70227906867618
PLA2G1B,Phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32818,0.0325912221399191,0.0373821133509959,-0.0406777200280329,0.105860164307871,0.383319029006876
PLA2G1B,Phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32818,-0.00646510634350123,0.0417788764832423,-0.0883517042506562,0.0754214915636538,0.877025195120866
PLA2G1B,Phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32818,0.00099168005766551,0.0260056685175706,-0.0499794302367729,0.0519627903521039,0.969582309082903
PLA2G1B,Phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32818,0.0513472233818885,0.0280591793992002,-0.00364876824054391,0.106343215004321,0.0672888805607333
PLA2G1B,Phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32818,-0.00823102557797698,0.0281634891715219,-0.06343146435416,0.046969413198206,0.770095578890209
PLA2G1B,Phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32818,0.00426668878323854,0.0254379731703554,-0.045591738630658,0.0541251161971351,0.866800174747484
PLA2G1B,Phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32818,-0.000837937608028188,0.0342002722327088,-0.0678704711841374,0.066194595968081,0.980453607875303
PLA2G1B,Phospholipase A2,Mental health,X29076.Felt loved as a child,35036,0.0375457391049279,0.0421933891382831,-0.0451533036061069,0.120244781815963,0.373566207307417
PLA2G1B,Phospholipase A2,Mental health,X29077.Physically abused by family as a child,35040,-0.0705267254755598,0.0538908457653974,-0.176152783175739,0.0350993322246191,0.190664310423342
PLA2G1B,Phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35027,-0.0153119470572631,0.054880293716106,-0.122877322740831,0.0922534286263046,0.780245166851033
PLA2G1B,Phospholipase A2,Mental health,X29079.Sexually molested as a child,34945,-0.025554600163431,0.075204466751221,-0.172955354995824,0.121846154668962,0.734012362232505
PLA2G1B,Phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35022,0.0593244114229635,0.0629776830959239,-0.0641118474450474,0.182760670290974,0.346217633633467
PLA2G1B,Phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35029,-0.127864771253093,0.0748681485435412,-0.274606342398434,0.0188767998922479,0.0876889862156795
PLA2G1B,Phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34968,-0.072286989854062,0.059400396183221,-0.188711766373175,0.0441377866650512,0.223651161537603
PLA2G1B,Phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35035,0.0312993241039879,0.0661360056688113,-0.0983272470068822,0.160925895214858,0.636039118963694
PLA2G1B,Phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34998,-0.0292792078908088,0.092092469177315,-0.209780447478346,0.151222031696728,0.750541944174111
PLA2G1B,Phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34998,-0.0400920881086764,0.0898425346230234,-0.216183455969802,0.135999279752449,0.655426494340915
PLA2G1B,Phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,35034,-0.00926943853624866,0.0733182515793092,-0.152973211631695,0.134434334559197,0.89939586075634
PLA2G1B,Phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35041,0.00243475753149591,0.0510751962520948,-0.0976726271226099,0.102542142185602,0.961980049256776
PLA2G1B,Phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35042,-0.0721314374527604,0.0456646470173147,-0.161634145606697,0.0173712707011764,0.114228989557525
PLA2G1B,Phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,35053,-0.109877807261897,0.0727215342159648,-0.252412014325188,0.0326563998013941,0.130832207385716
PLA2G1B,Phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35039,-0.0803281679959525,0.0564875748028101,-0.19104381460946,0.0303874786175552,0.155039574940344
PLA2G1B,Phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35048,-0.370752649526619,0.0390778332331537,-0.4473452026636,-0.294160096389637,2.84362172415042e-21
PLA2G1B,Phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33926,-0.307147122451335,0.0436035577612553,-0.392610095663395,-0.221684149239274,1.98905397630302e-12
PLA2G1B,Phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33941,-0.311601672331857,0.0436808893622793,-0.397216215481924,-0.22598712918179,1.04508177800009e-12
PLA2G1B,Phospholipase A2,Mental health,X29104.Ever used cannabis,35034,0.0860473663592874,0.0511467738649724,-0.0142003104160585,0.186295043134633,0.0925266976721115
PLA2G1B,Phospholipase A2,Mental health,X29108.Ever thought that life not worth living,34988,0.00324076624835665,0.0466151263920335,-0.0881248814800289,0.0946064139767422,0.944575551299523
PLA2G1B,Phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35005,0.0490755087755587,0.0606945171095264,-0.069885744759113,0.16803676231023,0.418782223055376
PLA2G1B,Phospholipase A2,Mental health,X29111.Ever self-harmed,35024,0.0525847956838,0.095557646548835,-0.134708191551917,0.239877782919517,0.582128777364925
PLA2G1B,Phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35029,0.118775605172794,0.065392527890486,-0.0093937494925582,0.246944959838147,0.0693437618875102
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33516,-0.0130021224215249,0.0355705366844906,-0.0827203743231265,0.0567161294800766,0.714723317029045
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33516,0.0363318052548348,0.0276268519898481,-0.0178168246452674,0.090480435154937,0.188510782791543
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33516,-0.0135368057282663,0.0288804498326144,-0.0701424874001904,0.0430688759436579,0.63928132882522
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33516,-0.00360555625489106,0.0383995485802404,-0.0788686714721622,0.07165755896238,0.925193879985008
PLA2G1B,Phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35021,0.0867078369916971,0.0429929484657005,0.00244165799892418,0.17097401598447,0.0437411210839648
PLA2G1B,Phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35036,-0.0438679871723713,0.0411812687629721,-0.124583273947797,0.0368472996030541,0.286789779726624
PLA2G1B,Phospholipase A2,Mental health,X29154.Anxiety or depression today,35036,0.0235641072344727,0.0503635509525603,-0.0751484526325454,0.122276667101491,0.63987940453176
PLA2G1B,Phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,34794,-0.052027429273182,0.0400455617619598,-0.130516730326623,0.0264618717802592,0.193900688552685
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35001,-0.00703064322893768,0.00889520264535024,-0.0244652404138241,0.0104039539559488,0.429319225840939
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35001,0.00267691354116731,0.00883657930723361,-0.0146427819010106,0.0199966089833452,0.761944675109605
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35001,-0.0571841195477502,0.0109869548792812,-0.0787185511111414,-0.035649687984359,1.97737150701623e-07
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35001,0.0289335206662394,0.013095659680278,0.00326602769289438,0.0546010136395843,0.0271672552099773
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35001,0.0337242299806387,0.0203872127188172,-0.00623470694824302,0.0736831669095204,0.0981180154279135
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35001,0.0180222176793752,0.00955073225858295,-0.000697217547447421,0.0367416529061978,0.0591864996356493
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35000,-0.00335214909955203,0.0104708415752321,-0.023874998587007,0.017170700387903,0.748867203861344
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35000,0.00754420037795945,0.0148049286347978,-0.0214734597462443,0.0365618605021632,0.610360336361119
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35000,-0.0793265219795066,0.0239724284464283,-0.126312481734506,-0.032340562224507,0.000939023195908976
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35000,0.0447702726238208,0.0236300826133349,-0.00154468929831558,0.0910852345459572,0.0581672577538868
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35000,-0.0313583792218638,0.0313245371421962,-0.0927544720205682,0.0300377135768407,0.316809698486505
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35000,0.0122450231218626,0.0156848197305596,-0.0184972235500341,0.0429872697937594,0.434999886445104
PLA2G1B,Phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34814,-0.0240984636434761,0.0488400771668389,-0.11982501489048,0.0716280876035282,0.621728743839717
PLA2G1B,Phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,34952,0.0784992760163426,0.0446400172690221,-0.00899515783094061,0.165993709863626,0.0786907879058178
PLA2G1B,Phospholipase A2,Mental health,X29173.Frequency of feeling left out,34905,0.0509156282119097,0.0457883336089358,-0.0388295056616044,0.140660762085424,0.266171734031838
PLA2G1B,Phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,34937,0.0215342268510943,0.0474319209013771,-0.0714323381156047,0.114500791817793,0.649835677597849
PLA2G1B,Phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35019,-0.00936460940499249,0.0397506828812205,-0.0872759478521848,0.0685467290421998,0.813760116557527
PLA2G1B,Phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35019,0.0104382208163799,0.0390108976057374,-0.0660231384908655,0.0868995801236253,0.789033793207542
PLA2G1B,Phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35019,-0.0217573387607819,0.0394607734757841,-0.0991004547733188,0.055585777251755,0.581393673196583
PLA2G1B,Phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35019,0.0524486746080811,0.0391618662497387,-0.0243085832414067,0.129205932457569,0.180507067890605
PLA2G1B,Phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35019,-0.0545842726984712,0.0394716844425918,-0.131948774205951,0.0227802288090087,0.166731907373142
PLA2G1B,Phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35019,0.0316820290853917,0.0393279220099682,-0.045400698054146,0.108764756224929,0.42049868680026
PLA2G1B,Phospholipase A2,Mental health,X29181.General happiness,34950,0.020069780407061,0.0408263602561025,-0.0599498856948999,0.100089446509022,0.623019813220462
PLA2G1B,Phospholipase A2,Mental health,X29182.Belief that own life is meaningful,34845,-0.0208479545153402,0.0405250318375605,-0.100277016916959,0.0585811078862784,0.606950316345309
PLA2G1B,Phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28937,-0.078593743243578,0.0560739270701364,-0.188498640301045,0.0313111538138893,0.161093059262138
PLA2G1B,Phospholipase A2,Health and medical history,X2946.Father's age,34186,0.01784844064878,0.0066709851839167,0.00477330968830323,0.0309235716092567,0.00747282118204431
PLA2G1B,Phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,29115,-0.0335761127607487,0.0118808525721449,-0.0568625838021528,-0.0102896417193446,0.00473009787779242
PLA2G1B,Phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51514,-0.0142407131074881,0.00288984723773735,-0.0199048136934533,-0.00857661252152292,8.36227185077494e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51514,0.0306896057648069,0.00340663836591223,0.024012594567619,0.0373666169619949,2.21471268450555e-19
PLA2G1B,Phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51514,0.00923141374934749,0.00363416482519486,0.00210845069196557,0.0163543768067294,0.0110851315552346
PLA2G1B,Phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51514,0.0181654501152958,0.00355791161384952,0.0111919433521507,0.0251389568784408,3.31844098298941e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51514,-0.0207349398476456,0.00288692054073076,-0.0263933041074778,-0.0150765755878133,7.02427458188232e-13
PLA2G1B,Phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51513,-0.0283014640982432,0.00289170676865812,-0.0339692093648132,-0.0226337188316733,1.39168050546671e-22
PLA2G1B,Phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51513,-0.0183928912941982,0.00282198927821624,-0.023923990279502,-0.0128617923088943,7.26198418739072e-11
PLA2G1B,Phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51514,0.0150634394140497,0.00275393896538316,0.00966571904189873,0.0204611597862007,4.54496169073434e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30080.Platelet count,51514,-0.0089781039718041,0.00291152028946613,-0.0146846837391577,-0.00327152420445048,0.00204680702535596
PLA2G1B,Phospholipase A2,Blood and urine assays,X30090.Platelet crit,51514,-0.00726536035770732,0.00298222165484282,-0.0131105148011993,-0.00142020591421538,0.0148477532156253
PLA2G1B,Phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51514,0.00514105354583965,0.00280896266584051,-0.000364513279207737,0.010646620370887,0.0672260020160964
PLA2G1B,Phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51514,-0.00202622599233039,0.00278191918226034,-0.00747878758956066,0.00342633560489987,0.466402195485215
PLA2G1B,Phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51476,-0.0106636481374445,0.00294161401932083,-0.0164292116153133,-0.00489808465957566,0.000289367472283822
PLA2G1B,Phospholipase A2,Blood and urine assays,X30130.Monocyte count,51476,-0.0123204297078061,0.00293140808084238,-0.0180659895462572,-0.00657486986935508,2.64339141889477e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51476,-0.012909260709051,0.00286113973266851,-0.0185170945850813,-0.00730142683302071,6.45052395915024e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51476,0.00204132971187622,0.00280898755316656,-0.00346428589233023,0.00754694531608267,0.467407524499216
PLA2G1B,Phospholipase A2,Blood and urine assays,X30160.Basophill count,51476,-0.0246280148973493,0.02661522832143,-0.076793862407352,0.0275378326126535,0.354799518103642
PLA2G1B,Phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51476,0.26399994313186,0.110398879721946,0.0476181388768462,0.480381747386874,0.0167941948871547
PLA2G1B,Phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51476,0.00317608979104795,0.00288757081053726,-0.00248354899760508,0.00883572857970098,0.27137763830562
PLA2G1B,Phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51476,-0.00238283518847727,0.0028929771879626,-0.00805307047688398,0.00328740009992943,0.41013878666263
PLA2G1B,Phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51476,-0.00350004350923027,0.00284463218377195,-0.0090755225894233,0.00207543557096276,0.218556771749342
PLA2G1B,Phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51476,0.00727068237694355,0.00277302567982303,0.00183555204449042,0.0127058127093967,0.00874810500110835
PLA2G1B,Phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51476,-0.00118526989177209,0.00275829036371176,-0.00659151900464714,0.00422097922110296,0.667408658033525
PLA2G1B,Phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51475,0.262476883397602,0.11068072482702,0.0455426627366418,0.479411104058561,0.0177239289197849
PLA2G1B,Phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51024,-0.0348180547807811,0.00295107230164181,-0.040602156491999,-0.0290339530695631,4.76153072703847e-32
PLA2G1B,Phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51024,-0.0298340438147027,0.00302851416286118,-0.0357699315739106,-0.0238981560554948,7.408923424743e-23
PLA2G1B,Phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51024,-0.00891350803318838,0.00286075217851692,-0.0145205823030815,-0.00330643376329523,0.00183642849221292
PLA2G1B,Phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51024,-0.0180896871731826,0.00287440877356968,-0.0237235283693792,-0.0124558459769861,3.15408616653884e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51024,-0.0219429477111265,0.00298223187401674,-0.0277881221841994,-0.0160977732380537,1.92124685731035e-13
PLA2G1B,Phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51024,-0.0373714753854485,0.00301663947758072,-0.0432840887615067,-0.0314588620093903,3.75648807528817e-35
PLA2G1B,Phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51024,-0.0335616153209279,0.00306991335096488,-0.0395786454888191,-0.0275445851530368,9.21566838194242e-28
PLA2G1B,Phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,32137,0.0208936512277601,0.0055953058912697,0.00992685168087153,0.0318604507746488,0.000189622379102899
PLA2G1B,Phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51638,0.0076428507027631,0.00294021954356303,0.00188002039737956,0.0134056810081466,0.009343218835984
PLA2G1B,Phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51576,-0.00593770063718528,0.00272472588958774,-0.0112781633807772,-0.000597237893593306,0.0293258055505028
PLA2G1B,Phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51578,-0.0318943672434589,0.00282678910507752,-0.0374348738894109,-0.026353860597507,1.84839750654227e-29
PLA2G1B,Phospholipase A2,Blood and urine assays,X30600.Albumin,48823,0.00253052752836956,0.00303648989785592,-0.00342099267142806,0.00848204772816717,0.40464258757805
PLA2G1B,Phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,51116,-0.0010741494616114,0.00288264317150114,-0.00672413007775364,0.00457583115453084,0.709429285981778
PLA2G1B,Phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51106,-0.014176507148408,0.00304210963082824,-0.0201390420248313,-0.00821397227198465,3.17564222211371e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,48690,-0.0291341285659426,0.00330639801963097,-0.0356146686844193,-0.0226535884474659,1.3146639213494e-18
PLA2G1B,Phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50951,-0.00895223934905521,0.00292777252471279,-0.0146906734974923,-0.00321380520061814,0.00223262869619784
PLA2G1B,Phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,51025,-0.0022608110445274,0.00285789267846197,-0.00786228069431286,0.00334065860525807,0.428906399602066
PLA2G1B,Phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,46869,0.00330178166920672,0.00313819565638315,-0.00284908181730425,0.0094526451557177,0.292752146955105
PLA2G1B,Phospholipase A2,Blood and urine assays,X30670.Urea,51106,0.0641879237311625,0.00297260195437663,0.0583616239005844,0.0700142235617407,1.50912337689998e-102
PLA2G1B,Phospholipase A2,Blood and urine assays,X30680.Calcium,48819,0.0185785339988071,0.00295757657320046,0.0127816839153342,0.02437538408228,3.40470251713139e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30690.Cholesterol,51121,-0.00964036464435382,0.00300678030455156,-0.0155336540412749,-0.00374707524743275,0.00134651563648955
PLA2G1B,Phospholipase A2,Blood and urine assays,X30700.Creatinine,51110,0.154388361647607,0.00350157785722579,0.147525269047445,0.16125145424777,0
PLA2G1B,Phospholipase A2,Blood and urine assays,X30710.C-reactive protein,51037,-0.0240896469252086,0.00312199284765351,-0.0302087529066095,-0.0179705409438078,1.24035820028574e-14
PLA2G1B,Phospholipase A2,Blood and urine assays,X30720.Cystatin C,51115,0.11105388299216,0.00327941334373879,0.104626232838432,0.117481533145888,2.88259023489924e-246
PLA2G1B,Phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,51106,-0.0339371387120828,0.00309902249545936,-0.0400112228031831,-0.0278630546209824,7.51922603426046e-28
PLA2G1B,Phospholipase A2,Blood and urine assays,X30740.Glucose,48785,-0.0504568376888387,0.00299206300799605,-0.056321281184511,-0.0445923941931664,1.87625285606917e-63
PLA2G1B,Phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50862,-0.0130832707700664,0.00304030830152387,-0.0190422750410532,-0.00712426649907961,1.68886464933253e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,48803,-0.0134005528077756,0.00350758890021683,-0.0202754270522006,-0.00652567856335061,0.00013353358155954
PLA2G1B,Phospholipase A2,Blood and urine assays,X30770.IGF-1,50993,0.0506565205143575,0.00294364007179564,0.0448869859736381,0.056426055055077,5.1154371777442e-66
PLA2G1B,Phospholipase A2,Blood and urine assays,X30780.LDL direct,51062,-0.00121132204406346,0.00297577633879174,-0.00704384366809527,0.00462119957996836,0.68396650001763
PLA2G1B,Phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,45675,0.00898796577108749,0.00315053544115803,0.00281291630641775,0.0151630152357572,0.00433715145870923
PLA2G1B,Phospholipase A2,Blood and urine assays,X30810.Phosphate,48757,0.0278978805286546,0.00295508422067421,0.0221059154561331,0.033689845601176,4.01917710280255e-21
PLA2G1B,Phospholipase A2,Blood and urine assays,X30830.SHBG,48571,0.0128915985643721,0.00343235976696623,0.00616417342111828,0.0196190237076259,0.000173116198018281
PLA2G1B,Phospholipase A2,Blood and urine assays,X30840.Total bilirubin,51014,0.00697900401376745,0.00291633409617998,0.00126298918525469,0.0126950188422802,0.0167146094464335
PLA2G1B,Phospholipase A2,Blood and urine assays,X30850.Testosterone,48940,-0.00154874136022336,0.0048997488081382,-0.0111522490241742,0.0080547663037275,0.751939962544067
PLA2G1B,Phospholipase A2,Blood and urine assays,X30860.Total protein,48803,0.00809445521854042,0.00300152237411495,0.00221147136527511,0.0139774390718057,0.0070059845529476
PLA2G1B,Phospholipase A2,Blood and urine assays,X30870.Triglycerides,51097,-0.0189443298281798,0.00299398677149922,-0.0248125439003182,-0.0130761157560413,2.53104724980756e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30880.Urate,51085,0.021004480279137,0.00360219090065288,0.0139441861138573,0.0280647744444166,5.57082996541096e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30890.Vitamin D,50009,0.0269289850124204,0.00310195049920673,0.0208491620339752,0.0330088079908656,4.13627602374367e-18
PLA2G1B,Phospholipase A2,Physical measures,X3137.Number of measurements made,50139,-0.0420857947166539,0.0306658052327674,-0.102190772972878,0.0180191835395702,0.169950221172299
PLA2G1B,Phospholipase A2,Physical measures,X3143.Ankle spacing width,40081,-0.0202995901614882,0.00512458917420042,-0.030343784942921,-0.0102553953800554,7.48886837195103e-05
PLA2G1B,Phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40080,0.00567164958951147,0.00393515631630392,-0.00204125679044421,0.0133845559694672,0.149525797326539
PLA2G1B,Phospholipase A2,Physical measures,X3146.Speed of sound through heel,40081,0.0135720874304582,0.00382348609323101,0.00607805468772547,0.021066120173191,0.000386815528313195
PLA2G1B,Phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40081,0.0111288402269399,0.00386130499340031,0.00356068243987526,0.0186969980140045,0.00395496545066172
PLA2G1B,Phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),40071,0.0110763738820398,0.0038670906789759,0.00349687615124706,0.0186558716128326,0.00418514377971749
PLA2G1B,Phospholipase A2,Health and medical history,X3526.Mother's age at death,35427,0.00832485837069265,0.00519566298129387,-0.00185864107264333,0.0185083578140286,0.109123075577095
PLA2G1B,Phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),30440,0.00287771430407275,0.00704004235692525,-0.0109207687155007,0.0166761973236462,0.682726325646845
PLA2G1B,Phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30409,0.00559315939624835,0.00644475289013196,-0.0070385562684103,0.018224875060907,0.385501405815514
PLA2G1B,Phospholipase A2,Physical measures,X4100.Ankle spacing width (left),32874,-0.014278773638273,0.00668540721036478,-0.027382171770588,-0.00117537550595807,0.0327215988695138
PLA2G1B,Phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32873,0.00681733492896173,0.00515832044556736,-0.00329297314435029,0.0169276430022738,0.186328558078035
PLA2G1B,Phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),32874,0.0149947832883296,0.00503149685071277,0.00513304946093261,0.0248565171157267,0.00288844544739523
PLA2G1B,Phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32874,0.0123036096359121,0.00507753697431216,0.00235163716626025,0.0222555821055639,0.0154063383450935
PLA2G1B,Phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32866,0.0115331274167693,0.00509050302878328,0.00155574148035406,0.0215105133531845,0.0234985170234754
PLA2G1B,Phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32874,0.0123031445042606,0.00507758705518554,0.00235107387609693,0.0222552151324242,0.0154112344757028
PLA2G1B,Phospholipase A2,Physical measures,X4119.Ankle spacing width (right),32864,-0.0195358381444213,0.00656054008065542,-0.0323944967025059,-0.00667717958633667,0.00291118612364078
PLA2G1B,Phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32864,0.0100162679385545,0.00519309174482245,-0.000162191881297482,0.0201947277584065,0.0537910958886551
PLA2G1B,Phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),32864,0.0143035492966256,0.00505064787058225,0.00440427947028433,0.0242028191229668,0.00463572285658754
PLA2G1B,Phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32864,0.0127926651326592,0.00510196687311141,0.00279281006136087,0.0227925202039576,0.0121798068002265
PLA2G1B,Phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32854,0.0136616962526309,0.00512288061826409,0.0036208502408333,0.0237025422644285,0.00767143613298345
PLA2G1B,Phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32864,0.0127918908375002,0.00510198588535905,0.00279199850219643,0.0227917831728039,0.0121853561252359
PLA2G1B,Phospholipase A2,Physical measures,X4194.Pulse rate,33163,-0.0374531430784329,0.00487510764191592,-0.0470083540565881,-0.0278979321002777,1.71759216888008e-14
PLA2G1B,Phospholipase A2,Physical measures,X4195.Pulse wave reflection index,33163,0.0100161190037098,0.00478538331038295,0.000636767715359267,0.0193954702920604,0.0363703560184861
PLA2G1B,Phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,33158,0.0222152117813847,0.00514301914972104,0.0121348942479314,0.0322955293148379,1.58015389695379e-05
PLA2G1B,Phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,33163,-0.0247324880142698,0.00491307987987664,-0.0343621245788281,-0.0151028514497116,4.89328236258085e-07
PLA2G1B,Phospholipase A2,Physical measures,X4199.Position of pulse wave notch,33163,-0.0237414581960879,0.00483395867627832,-0.0332160172015934,-0.0142668991905824,9.19726681879e-07
PLA2G1B,Phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33163,-0.0259305141955697,0.00503463380710559,-0.0357983964574967,-0.0160626319336428,2.65217701553635e-07
PLA2G1B,Phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),33030,-0.15163938283608,0.144658251683213,-0.435169556135177,0.131890790463017,0.294546745076972
PLA2G1B,Phospholipase A2,Physical measures,X4270.Volume level set by participant (left),32944,0.0257403538296489,0.042417384687622,-0.0573977201580902,0.108878427817388,0.543975586004424
PLA2G1B,Phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),33037,0.0425997607864976,0.141173403242556,-0.234100109568912,0.319299631141907,0.762845790042596
PLA2G1B,Phospholipase A2,Physical measures,X4277.Volume level set by participant (right),32933,0.0455421949614424,0.0424323433268491,-0.037625197959182,0.128709587882067,0.283169731049874
PLA2G1B,Phospholipase A2,Cognitive function,X4288.Time to answer,33197,0.0109970242603127,0.00553699920275949,0.000144505822904085,0.0218495426977213,0.0470516111789479
PLA2G1B,Phospholipase A2,Cognitive function,X4290.Duration screen displayed,33197,0.00434764334713782,0.00492326700790556,-0.00530195998835707,0.0139972466826327,0.377215266983436
PLA2G1B,Phospholipase A2,Physical measures,X46.Hand grip strength (left),52347,-0.00793745925243262,0.00392322228365884,-0.0156269749284039,-0.000247943576461295,0.0430619588682351
PLA2G1B,Phospholipase A2,Physical measures,X47.Hand grip strength (right),52326,-0.00744059603367248,0.00388267615765302,-0.0150506413026724,0.000169449235327444,0.0553295942807743
PLA2G1B,Phospholipase A2,Physical measures,X48.Waist circumference,52405,-0.0820889490568701,0.00612331601646315,-0.0940906484491378,-0.0700872496646023,7.41802204657493e-41
PLA2G1B,Phospholipase A2,Health and medical history,X4803.Tinnitus,32986,0.00154218628516408,0.051897281603437,-0.100176485657572,0.103260858227901,0.976294098987429
PLA2G1B,Phospholipase A2,Working and living environment,X4825.Noisy workplace,33120,-0.0692750802856424,0.0565309977106749,-0.180075835798565,0.0415256752272804,0.220442426115698
PLA2G1B,Phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,33059,0.0337132260891647,0.0617309079620345,-0.087279353516423,0.154705805694752,0.584988430945763
PLA2G1B,Phospholipase A2,Physical measures,X49.Hip circumference,52401,-0.00515627362078455,0.00485274883009656,-0.0146676613277738,0.00435511408620471,0.287996431739094
PLA2G1B,Phospholipase A2,Physical measures,X50.Standing height,52376,-0.0218308060628089,0.00384056725608445,-0.0293583178847344,-0.0143032942408834,1.32656833297876e-08
PLA2G1B,Phospholipase A2,Health and medical history,X5057.Number of older siblings,32316,0.0798981303207994,0.0452003631369095,-0.0086945814275433,0.168490842069142,0.0771565748516335
PLA2G1B,Phospholipase A2,Physical measures,X51.Seated height,52236,-0.0125547641522557,0.00356568131218593,-0.0195434995241401,-0.00556602878037128,0.000430596664139908
PLA2G1B,Phospholipase A2,Eye measures,X5181.Ever had eye surgery,30170,-0.0848734802607881,0.110220519100341,-0.300905697697457,0.131158737175881,0.441308920357463
PLA2G1B,Phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30155,0.004654538163717,0.00608588110349005,-0.00727378879912349,0.0165828651265575,0.444413808074569
PLA2G1B,Phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30153,0.00737951707330302,0.00604445960144,-0.00446762374551938,0.0192266578921254,0.222179877745186
PLA2G1B,Phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),30099,0.0112513452212435,0.005970391536977,-0.000450622191231445,0.0229533126337184,0.0595405983033811
PLA2G1B,Phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),30097,0.0107994337258652,0.00597929766960149,-0.000919989706553716,0.0225188571582841,0.0709450516106703
PLA2G1B,Phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",30132,-0.119014600926917,0.0522830007371419,-0.221489282371716,-0.0165399194821193,0.0228584066439555
PLA2G1B,Phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),30132,0.0611358570827488,0.393859359004957,-0.710828486566967,0.833100200732465,0.876650861841981
PLA2G1B,Phospholipase A2,Eye measures,"X5201.logMAR, final (right)",30078,-0.00972204252725596,0.00578452541117568,-0.0210597123331603,0.00161562727864836,0.092871740470103
PLA2G1B,Phospholipase A2,Eye measures,X5202.Number of rounds to result (right),30132,-0.0370475126336715,0.0500770596269315,-0.135198549502457,0.0611035242351144,0.459442990097692
PLA2G1B,Phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",30129,-0.0944413959437644,0.051841094759439,-0.196049941672265,0.00716714978473595,0.0685409116004115
PLA2G1B,Phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),30129,-0.500710226020593,0.340252719126183,-1.16760555550791,0.166185103466725,0.141183643233333
PLA2G1B,Phospholipase A2,Eye measures,"X5208.logMAR, final (left)",30078,-0.0144741897581826,0.00577449787138708,-0.0257922055861012,-0.0031561739302639,0.0122161725549865
PLA2G1B,Phospholipase A2,Eye measures,X5209.Number of rounds to result (left),30125,0.0492820244817613,0.0497958172228759,-0.0483177772750754,0.146881826238598,0.322367858626381
PLA2G1B,Phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29886,0.00611864841388926,0.00597876624289074,-0.00559973342217658,0.0178370302499551,0.306161497085041
PLA2G1B,Phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29886,-0.00135823909789905,0.00586891649450719,-0.0128613154271331,0.010144837231335,0.816989180683317
PLA2G1B,Phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),29886,-0.0118302883674553,0.00602480753618134,-0.0236389111383707,-2.16655965398736e-05,0.0496228662774305
PLA2G1B,Phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),29886,-0.00939199157839596,0.0059091937408914,-0.0209740113105431,0.00219002815375118,0.112025665146672
PLA2G1B,Phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29865,0.000752521132645341,0.00603460547986918,-0.0110753056078983,0.0125803478731889,0.900764466631079
PLA2G1B,Phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29865,0.000375945207266121,0.00589287283080635,-0.0111740855411143,0.0119259759556466,0.949134314859299
PLA2G1B,Phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),29865,-0.000524825545349213,0.00600801638931598,-0.0123005376684085,0.0112508865777101,0.930392875302522
PLA2G1B,Phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),29865,-0.000239875911603654,0.00588872873290263,-0.0117817842280928,0.0113020324048855,0.967508709730837
PLA2G1B,Phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29973,0.0914885134594301,0.206671868147253,-0.313588348109186,0.496565375028047,0.658016338132152
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52305,-0.00777435076388195,0.0168008210992887,-0.0407039601184878,0.0251552585907239,0.643556893801929
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52305,-0.0551148091237484,0.0187791802291567,-0.0919220023728955,-0.0183076158746012,0.00333933748605955
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52305,0.0260794173781203,0.0438738455896687,-0.0599133199776303,0.112072154733871,0.552237089111161
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52305,-0.0368481607210271,0.00774299971436789,-0.0520244401611881,-0.021671881280866,1.95606422741737e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52305,0.0350911280737217,0.00694156794300545,0.021485654905431,0.0486966012420124,4.3256748011515e-07
PLA2G1B,Phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38018,-0.0019345605346344,0.00801227169628558,-0.0176386130593541,0.0137694919900854,0.809210099570142
PLA2G1B,Phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38018,-0.00378709414998312,0.0285518293311986,-0.0597486796391324,0.0521744913391662,0.894480549075258
PLA2G1B,Phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38018,-0.0147087705152592,0.0136339700238936,-0.0414313517620905,0.0120138107315722,0.280680765007446
PLA2G1B,Phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38018,-0.024493741426398,0.00864577844711864,-0.0414394671827505,-0.00754801567004543,0.00461743507406495
PLA2G1B,Phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52388,-0.0154266126226742,0.0156939992838124,-0.0461868512189464,0.015333625973598,0.325634236018488
PLA2G1B,Phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52388,-0.0154266126226742,0.0156939992838124,-0.0461868512189464,0.015333625973598,0.325634236018488
PLA2G1B,Phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52388,-0.010081364569869,0.011501391382475,-0.0326240916795201,0.012461362539782,0.380746994053291
PLA2G1B,Phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52388,0.0143205519376866,0.0178550152005769,-0.0206752778554441,0.0493163817308172,0.422532757950452
PLA2G1B,Phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52388,-0.0429346339896691,0.0437009850801985,-0.128588564746858,0.0427192967675199,0.325879761423421
PLA2G1B,Phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52388,0.0353798662901145,0.0306144539473747,-0.0246244634467399,0.095384196026969,0.247830382698143
PLA2G1B,Phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52388,-0.00328127944934721,0.0462752326822575,-0.0939807355065718,0.0874181766078774,0.943471555050702
PLA2G1B,Phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52304,0.0214012906366187,0.00880475377625604,0.00414397323515689,0.0386586080380805,0.0150778297269586
PLA2G1B,Phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52304,-0.00984522175970111,0.0151887834185606,-0.0396152372600798,0.0199247937406776,0.516867120856241
PLA2G1B,Phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52304,-0.0119594270162315,0.00739699410280588,-0.0264575354577311,0.00253868142526798,0.105933513511343
PLA2G1B,Phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52304,-0.0083281010566642,0.0139484488151249,-0.035667060734309,0.0190108586209806,0.550470150445988
PLA2G1B,Phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52304,-0.0017966460364159,0.0121078808661872,-0.0255280925341428,0.021934800461311,0.882038807238488
PLA2G1B,Phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52304,0.00602880510597208,0.00984256044024385,-0.0132626133569059,0.02532022356885,0.540195979440638
PLA2G1B,Phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30164,0.077027368306071,0.0281391489838234,0.0218746362977771,0.132180100314365,0.00621055907160341
PLA2G1B,Phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30164,0.068977833576903,0.0245024676747104,0.0209529969344706,0.117002670219335,0.0048907544684908
PLA2G1B,Phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30164,0.068007100728869,0.0307724152592291,0.0076931668207799,0.128321034636958,0.0271408168192279
PLA2G1B,Phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30164,-0.0678273915765746,0.0252442963441861,-0.117306212411179,-0.0183485707419699,0.00723206637244411
PLA2G1B,Phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52256,-0.0444637951045613,0.0243890174768645,-0.0922662693592158,0.00333867915009317,0.0682976544305424
PLA2G1B,Phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52256,-0.0126717171993767,0.0352675080832963,-0.0817960330426375,0.0564525986438841,0.7193711922564
PLA2G1B,Phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52256,-0.0183100711201065,0.0727236008924315,-0.160848328869272,0.124228186629059,0.801215884638523
PLA2G1B,Phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52256,-0.0425473738701986,0.063173690543358,-0.16636780733518,0.0812730595947831,0.500635804582506
PLA2G1B,Phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52256,-0.011668684133896,0.0227538844154795,-0.0562662975882357,0.0329289293204438,0.60808008584849
PLA2G1B,Phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52256,0.00927455920739163,0.02891327126685,-0.0473954524756344,0.0659445708904177,0.748385766840362
PLA2G1B,Phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52256,-0.0277608039690855,0.0118349890313008,-0.050957382470435,-0.00456422546773604,0.0190005096816951
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33685,0.026566080064624,0.0224543487855606,-0.0174444435550747,0.0705766036843228,0.23679214437346
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33685,-0.0671963794493538,0.0253797235843549,-0.116940637674689,-0.0174521212240181,0.00811851292024221
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33685,0.0328262212497397,0.0325759777254698,-0.0310226950921811,0.0966751375916605,0.313632040565497
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33685,-0.0165091316084525,0.00971160701784176,-0.0355438813634223,0.00252561814651736,0.0891742049616164
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35880,4.80960643956605e-05,0.0111327170788659,-0.0217720294101815,0.0218682215389728,0.996553025697195
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35880,0.00680450272392701,0.00900123482526552,-0.0108379175335934,0.0244469229814474,0.449692705585025
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35880,0.00460132395992855,0.0089073096351675,-0.0128570029249997,0.0220596508448568,0.605459985070298
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35881,0.0179651781242273,0.0216603931695186,-0.0244891924880291,0.0604195487364837,0.406893316229433
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35881,-0.0022671672418159,0.0142336434195132,-0.0301651083440618,0.02563077386043,0.873449153347756
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35881,-0.0536550696064756,0.0177544775565002,-0.088453845617216,-0.0188562935957352,0.00251590537185663
PLA2G1B,Phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52304,-0.0204808968336707,0.0205232128661315,-0.0607063940512884,0.019744600383947,0.318317846307543
PLA2G1B,Phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52304,-0.0211363978712517,0.0134333636441251,-0.0474657906137369,0.00519299487123354,0.115631431823578
PLA2G1B,Phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52304,-0.0124817515482203,0.040429947689796,-0.0917244490202204,0.0667609459237797,0.757532685855751
PLA2G1B,Phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52304,0.0210471207009916,0.0151409591878724,-0.00862915930723825,0.0507234007092215,0.16451594172602
PLA2G1B,Phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52304,-0.00681401130665192,0.0166338696025679,-0.0394163957276851,0.0257883731143813,0.68206815219728
PLA2G1B,Phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52304,-0.00128653382351805,0.0184076877147965,-0.0373656017445191,0.034792534097483,0.944280816163231
PLA2G1B,Phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52304,0.00315133084974204,0.00592159805638046,-0.00845500134076367,0.0147576630402477,0.594608437803628
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28144,0.0386255660618939,0.0197656997325096,-0.000115205413824856,0.0773663375376126,0.0507459172693719
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28144,-0.00169147671339619,0.0250703038975015,-0.0508292723524992,0.0474463189257068,0.946211222637572
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28144,-0.00200956589225906,0.0183780621697821,-0.038030567745032,0.0340114359605138,0.912933257042165
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28144,-0.00388051643954029,0.0152561877892758,-0.0337826445065208,0.0260216116274402,0.799232062533041
PLA2G1B,Phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52441,0.0139436525368619,0.0063451548668772,0.00150714899778254,0.0263801560759412,0.0279907854248938
PLA2G1B,Phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52441,-0.0214350497421484,0.0186444859791044,-0.057978242261193,0.0151081427768963,0.250288472631907
PLA2G1B,Phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52441,-0.00256422160221157,0.00640548120313214,-0.0151189647603506,0.00999052155592742,0.688926203162115
PLA2G1B,Phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52441,-0.0079452682770391,0.00622980340852155,-0.0201556829577413,0.00426514640366314,0.202190727935896
PLA2G1B,Phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52441,0.000352559403073985,0.00902384726416804,-0.0173341812346954,0.0180393000408434,0.968835056164016
PLA2G1B,Phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52441,-0.000334527455326084,0.0092730966779509,-0.0185097969441098,0.0178407420334577,0.971222766031584
PLA2G1B,Phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52441,-0.00145529587118935,0.00686240202426546,-0.0149056038387496,0.0119950120963709,0.832055496568934
PLA2G1B,Phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52441,-0.0242881444527132,0.019426524352193,-0.0623641321830115,0.0137878432775851,0.211215984730454
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43169,0.0173011124851207,0.00672943980040499,0.00411141047632689,0.0304908144939145,0.0101491581506206
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43169,-0.06662531222259,0.00705418426560085,-0.0804515133831676,-0.0527991110620123,3.95532555505423e-21
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43169,0.0339004953066646,0.00846067456327757,0.0173175731626406,0.0504834174506887,6.17695287198553e-05
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43170,0.0105089546410372,0.0116325290579112,-0.0122908023124687,0.0333087115945431,0.366319076670507
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43170,0.0195906979404193,0.00746040911405712,0.00496829607686737,0.0342130998039713,0.0086474414364981
PLA2G1B,Phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52198,-0.0124130902744405,0.00701435092213619,-0.0261612180818275,0.00133503753294639,0.0767927901244488
PLA2G1B,Phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52198,0.00282738482624734,0.00550138032081581,-0.00795532060255165,0.0136100902550463,0.607297258346901
PLA2G1B,Phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52198,-0.010861024937542,0.00656949310007027,-0.0237372314136797,0.00201518153859578,0.0982907470267138
PLA2G1B,Phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52198,0.0246661449999498,0.0102427823350244,0.00459029162330203,0.0447419983765976,0.016039984797684
PLA2G1B,Phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52214,0.00203024382661113,0.00604211305617935,-0.0098122977635004,0.0138727854167226,0.736861641084385
PLA2G1B,Phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52214,0.0356176911167452,0.00827111916823563,0.0194062975470034,0.0518290846864871,1.6658606109225e-05
PLA2G1B,Phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52304,0.00844242611869265,0.0063858299978718,-0.00407380067713608,0.0209586529145214,0.186160069905676
PLA2G1B,Phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52304,0.00423367614012359,0.00785764209882459,-0.0111673023735726,0.0196346546538198,0.590030961665985
PLA2G1B,Phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52304,0.0101213274305424,0.0117735297746666,-0.0129547909278042,0.0331974457888889,0.389979294468082
PLA2G1B,Phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52304,0.0181810934399462,0.0137152156694433,-0.00870072927216271,0.0450629161520551,0.184977954052809
PLA2G1B,Phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52304,0.0179835463249632,0.0135553082990576,-0.00858485794118971,0.0445519505911161,0.184625456582624
PLA2G1B,Phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52304,0.0348740146662088,0.0193350106595891,-0.00302260622658573,0.0727706355590034,0.0712933396263648
PLA2G1B,Phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40081,0.0111287722792295,0.00386132426894231,0.00356057671210258,0.0186969678463564,0.00395536673667367
PLA2G1B,Phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51911,0.00859645117733297,0.0237667263981327,-0.037986332563007,0.055179234917673,0.717578126904449
PLA2G1B,Phospholipase A2,Physical activities,X874.Duration of walks,48250,-0.00247017209349124,0.00285587105109266,-0.00806767935363285,0.00312733516665038,0.387077348043093
PLA2G1B,Phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51176,0.0135840891530135,0.0232799468687091,-0.0320446067096564,0.0592127850156833,0.559554633252666
PLA2G1B,Phospholipase A2,Physical activities,X894.Duration of moderate activity,45013,-0.0104044730707832,0.0278715926773612,-0.0650327947184112,0.0442238485768447,0.708928716498474
PLA2G1B,Phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30376,0.0111563784899602,0.00570751912128681,-3.03589877619394e-05,0.0223431159676823,0.0506634501372186
PLA2G1B,Phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51178,0.0806820015351199,0.0238482880032701,0.0339393570487104,0.127424646021529,0.000717637525337702
PLA2G1B,Phospholipase A2,Physical activities,X914.Duration of vigorous activity,40003,0.00652121960770888,0.00357866439041658,-0.000492962597507618,0.0135354018129254,0.068435620298798
